Nevro Corporation has announced that it has acquired Vyrsa Technologies—a privately held medical technology company focused on a minimally invasive treatment option for patients suffering from chronic sacroiliac (SI) joint pain.
Under the terms of the transaction, which signed and...
This advertorial, sponsored by Siemens Healthineers and intended for US readers only, is part of a series of articles on the emerging role for neurovascular office-based labs (OBLs).
Neurovascular diseases present formidable obstacles for both patients and healthcare providers. As...
Kaneka Corporation has acquired all shares of Japan Medical Device Technology and has made it a wholly owned subsidiary.
Kaneka manufactures and sells endovascular catheters, which are devices used in the treatment of cardiac, peripheral vascular and cerebrovascular diseases.
Kaneka is...
Nalu Medical has announced the publication of the spinal cord stimulation (SCS) nPower US clinical study in the Pain Physician Journal, reporting on clinical outcomes related to the use of the Nalu SCS system to treat patients suffering from chronic...
A comparative study recently demonstrated the promise held by PreSize Neurovascular (Oxford Heartbeat) software in consistently and accurately making predictions about flow-diverter placement in intracranial aneurysm treatments. However, according to lead study author Ansaar Rai (West Virginia University Rockefeller...
Intra-arterial tenecteplase has demonstrated potential as a safe and feasible adjunct to mechanical thrombectomy in patients with acute ischaemic stroke caused by a distal large vessel occlusion (LVO) who achieve “successful but incomplete” reperfusion, as per findings from the...
Theranica has announced the peer-reviewed publication of a comprehensive clinical study showing the preventive benefits of its remote electrical neuromodulation (REN) wearable, Nerivio, for adolescents suffering from migraine. The study—published in Frontiers in Pain Research—demonstrates that frequent use of...
In a guest piece for NeuroNews, Arūnė Simanavičienė (Kaunas, Lithuania) and Audrius Širvinskas (Vilnius, Lithuania) highlight the work being done by the Brain Aneurysm Foundation in Lithuania, and its attempts to boost awareness of the finer details of intracranial...
The multicentre, randomised SEGA trial has found that acute ischaemic stroke patients who receive endovascular therapy (EVT) under general anaesthesia experience better functional outcomes at 90 days compared to those who receive the procedure under conscious sedation.
These results—presented for...
Researchers from Germans Trias i Pujol Research Institute (IGTP; Badalona, Spain) have discovered that administering human apotransferrin to mice affected by intracranial haemorrhage (ICH) can mitigate the damaging effects of this severe type of stroke. Findings from an experimental...
Receiving intravenous tissue plasminogen activator (IV-tPA) in an ambulance-based mobile stroke unit (MSU) increases the likelihood of averting strokes and the odds of a patient achieving complete recovery compared with standard hospital emergency care, according to researchers at Weill...
Brainomix has heralded its continued US expansion with the launch of a full suite of US Food and Drug Administration (FDA)-cleared modules in its Brainomix 360 platform for stroke care.
The US launch—which included the company’s previously announced, FDA-cleared e-ASPECTS...
Nevro Corporation has announced the publication of new 24-month data from the SENZA-NSRBP multicentre randomised controlled trial (RCT) in the Journal of Neurosurgery: Spine. The published 24-month data detail outcomes for non-surgical refractory back pain (NSRBP) patients treated with Nevro's...
Route 92 Medical has announced it has raised more than US$31 million in a Series F financing round to accelerate the commercial adoption of a neurovascular intervention portfolio focused on acute ischaemic stroke. The oversubscribed capital raise was led...
Neurolutions and Kandu Health recently announced a strategic partnership intended to raise the standard of care for post-stroke recovery. Through this partnership, Kandu’s expert clinicians will support Neurolutions by providing clinical consultation and assessments of stroke survivors to determine...
Boston Scientific Corporation has announced the close of its acquisition of Relievant Medsystems—the company behind the US Food and Drug Administration (FDA)-cleared Intracept intraosseous nerve ablation system, which is used to treat a form of chronic low back pain...
The ATTEST-2 trial has found that tenecteplase was non-inferior to alteplase, the more established of the two thrombolytic agents, in suitable acute ischaemic stroke patients. Preliminary results from the study were presented by principal investigator Keith Muir (University of...
Rapid Medical has announced new data demonstrating “excellent” first-pass treatment success using the Tigertriever device in complex ischaemic stroke patients with underlying intracranial atherosclerotic disease (ICAD). The complication rates were also negligible, as reported at the ongoing Society of Vascular and...
Microvention, a wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation commemorating the anniversary of its Sofia and Sofia Flow Plus aspiration catheters, having performed more than half a million worldwide procedures across 170 countries,...
Route 92 Medical has announced new results from a multicentre clinical study evaluating the efficacy, safety and efficiency of the Tenzing 7 delivery catheter as a means for delivering therapeutic devices for mechanical thrombectomy in acute ischaemic stroke.
The results—now published in Stroke:...
A systematic review and meta-analysis of 1,356 studies and more than 410,000 patients have found that “methodological flaws and incomplete reporting” occur frequently in studies advocating the safety, effectiveness or durability of intracranial aneurysm treatments—forming a “potential public health...
The proliferation of new technologies and advancements in the neurosciences space has showed little sign of slowing in recent years and—as John Rolston (Boston, USA) avers in this guest piece for NeuroNews—patients with brain function diseases may well reap...
With a renewed focus on challenging cases, novel technologies and, overall, the most pressing issues in carotid treatments and acute stroke care, the 2024 Charing Cross (CX) Symposium (23–25 April, London, United Kingdom) intends to maximise audience participation throughout...
People who live in neighbourhoods with lower socioeconomic status are less likely to receive clot-busting medications or undergo mechanical thrombectomy procedures after they have a stroke compared to those living in neighbourhoods with a higher socioeconomic status. That is...
SpineX has reported in a press release that a publication titled, “A pilot study of the effect of transcutaneous spinal cord stimulation on micturition-related brain activity and lower urinary tract symptoms after stroke”, has been accepted by the Journal...
RapidAI announced today that it has received US Food and Drug Administration (FDA) clearance for Rapid SDH, its artificial intelligence (AI)-powered module for the detection and notification of suspected hemispheric acute and chronic subdural haematoma (SDH).
Together with Rapid ICH and Rapid Hyperdensity, both...
Rapid Medical has announced that the final patient has been enrolled in SUCCESS—a US Food and Drug Administration (FDA) post-market surveillance study assessing the safety and performance of the company's Comaneci embolisation assist device in the USA.
The final patient...
The principle of medical necessity “should drive all remote monitoring decisions” relating to spinal cord stimulation (SCS) technologies, according to recommendations recently published in Neuromodulation: Technology at the Neural Interface by a panel of pain management experts. The panel...
Surgical Information Sciences (SIS) has announced the commencement of its post-market VISION study evaluating visualisation of the subthalamic nucleus (STN) and globus pallidus internus (GPi) for deep brain stimulation (DBS) surgery in patients with Parkinson's disease.
This study aims to...
Perfuze has announced commencement of enrolment in its pivotal MARRS study—a multicentre trial set to evaluate the performance of aspiration thrombectomy with the company’s Millipede system for revascularisation in acute ischaemic stroke. The first patient was enrolled at Stony...
InspireMD recently presented 30-day results from the C-GUARDIANS US investigational device exemption (IDE) clinical trial evaluating its CGuard embolic prevention stent (EPS) system for stroke prevention at the annual Vascular Interventional Advances (VIVA) meeting (30 October–2 November 2023, Las...
New results from the TENSION study—presented recently at the 15th World Stroke Congress (WSC; 10–12 October, Toronto, Canada) by Götz Thomalla (University Medical Center Hamburg-Eppendorf, Hamburg, Germany)—have demonstrated improved functional outcomes and reduced mortality rates among stroke patients treated...
Contego Medical has announced the presentation of late-breaking clinical results from the PERFORMANCE II carotid stent trial at the annual Vascular Interventional Advances (VIVA) meeting (30 October–2 November 2023, Las Vegas, USA). PERFORMANCE II is a prospective, multicentre study...
Annalise.ai has announced the launch of Annalise Triage—an innovative software solution tailored specifically for the US market that the company claims will “transform the radiology field by empowering radiologists to efficiently triage studies and prioritise those with suspected critical...
A study demonstrating the successful deep-brain placement of a brain-computer interface (BCI) microchip into a living animal with no apparent neurological effects has been published in the journal Brain-Computer Interfaces, as per a press release from NICO Corporation.
The publication—led...
In a “notable departure” from prior iterations of the conference, this year’s Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–18 November, Miami, USA) will place a “distinct emphasis” on innovation, focusing on the latest technologies within interventional...
There are multiple components of the PROST randomised controlled trial’s (RCT) design that set it apart from prior studies and make it somewhat unique in the stroke thrombectomy space. At this year’s European Society of Minimally Invasive Neurological Therapy...
Surmodics has announced the commercial launch of its most advanced hydrophilic medical device coating technology, the Preside hydrophilic coatings.
As per a company press release, Preside hydrophilic coatings complement Surmodics’ existing Serene hydrophilic coatings by providing customers with a unique,...
MindRhythm has announced that the US Food and Drug Administration (FDA) has awarded a Breakthrough Device designation to its Harmony headset embedded with HeadPulse technology.
“This designation highlights the position that Harmony is truly breakthrough, as it acknowledges the...
A secondary analysis of existing clinical trial data has indicated that new ischaemic brain lesions detected via diffusion-weighted magnetic resonance imaging (DW-MRI) following carotid artery revascularisation—either with carotid artery stenting (CAS) or carotid endarterectomy (CEA)—do not appear to have...
In a new case report, researchers at University of California Los Angeles (UCLA) Health have described “promising results” using repetitive transcranial magnetic stimulation (rTMS) in the management of post-stroke cerebellar ataxia—a debilitating condition marked by impaired coordination and balance.
Ataxia...
Recently published data from two large randomised controlled trials (RCTs) have indicated there may be minimal benefits—or even negative effects—associated with bypassing local or primary stroke centres (PSCs) and transporting patients straight to thrombectomy-capable comprehensive stroke centres (CSCs). However,...
Cordance Medical has announced that its device, NeuroAccess, has been granted Breakthrough Device designation by the US Food and Drug Administration (FDA), meaning the company will receive prioritised review and accelerated interaction with the regulator.
The NeuroAccess device is engineered...
Ahead of World Stroke Day 2023, on 29 October, physicians from the Get Ahead of Stroke campaign are highlighting the fact that, while prevalence of stroke in the USA is declining in adults aged 75 years and older, it...
EOSolutions Corporation has announced that the US Food and Drug Administration (FDA) has cleared its Thinline introducer sheath—an approval that swiftly follows the successful launch of the company’s “revolutionary” Dr Banner balloon guide catheter (BGC) in the USA.
The Thinline...
Cognito Therapeutics has announced that continued active treatment with the company’s gamma sensory stimulation technology in the Phase 2 OVERTURE open label extension (OLE) study demonstrated durability and concordance of clinical and magnetic resonance imaging (MRI) benefits over 18...
Digital health company Butterfly Network and deep tech research firm Forest Neurotech announced yesterday that they have entered into a five-year co-development agreement to further the development of next-generation brain-computer interfaces (BCIs) using Butterfly’s semiconductor-based Ultrasound-on-Chip technology.
The agreement includes...
While the latest thrombectomy techniques, thrombolytic drug candidates and even neuroprotective agents are the source of much discussion in today’s neurovascular space, there is also significant room for improvement within another step along the stroke care pathway: patient triage....
Researchers at the UK Dementia Research Institute (DRI) have developed a new form of deep brain stimulation (DBS) that does not require surgery and could provide an alternative treatment option for brain diseases like Alzheimer’s.
The technology—based on temporal interference...
A specialised ‘brain-wave cap’, designed by researchers in The Netherlands, may be able to diagnose stroke patients while they are in an ambulance—thus allowing them to receive appropriate treatments more quickly.
"Our research shows that the brain-wave cap can recognise...
Robocath has today announced the results of its CARE clinical trial focusing on robotic carotid stenting—the first phase of a research programme launched in July 2021 by Robocath and Rennes University Hospital (Rennes, France), which, in the long term,...
SynerFuse has announced that it has completed enrolment in its proof-of-concept study to evaluate the safety and tolerability of the Electric Transforaminal Lumbar Interbody Fusion (e-TLIF) procedure integrating spinal fusion with direct nerve stimulation, which is designed to treat...
The third Stroke Recovery and Rehabilitation Roundtable—an initiative of the International Stroke Recovery and Rehabilitation Alliance (ISRRA)—has made a series of key recommendations about managing fatigue, measuring mobility, harnessing non-invasive brain stimulation technologies, and improving how trials are designed,...
The existing body of evidence supporting artificial intelligence (AI) and the autonomous navigation of endovascular procedures is “inadequate”, despite the theoretical benefits held by this “promising” concept.
This is among the concluding messages delivered by Thomas Booth (Kings College Hospital,...
Administering 10Hz cerebellar repetitive transcranial magnetic stimulation (rTMS) offers a “promising”, non-invasive treatment option in patients experiencing dysphagia following a subacute infratentorial stroke, as per the findings of a recent randomised controlled trial (RCT).
Writing in the journal Brain Stimulation,...
Anaconda Biomed has announced that the European Patent Office has granted the company a European patent for “A device and a thrombectomy apparatus for extraction of thrombus from a blood vessel”, published as patent number EP 3866708 B1 on...
Imperative Care recently announced the publication of clinical data in the journal Interventional Neuroradiology (INR) detailing the use of its Zoom aspiration catheters in patients with large and medium vessel occlusion stroke.
Data from an independent study evaluating real-world experiences...
Athersys has announced that the independent data safety monitoring board (DSMB) has completed a preplanned interim analysis of the company’s ongoing, phase three MASTERS-2 pivotal clinical trial evaluating MultiStem (invimestrocel) for the treatment of moderate-to-severe acute ischaemic stroke. The...
Discussions at this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France) revealed the extent of the disparities between the current regulatory systems in Europe and the USA, with experts and attendees outlining how “the...
The Nautilus system (Endostream Medical)—a self-conforming intrasaccular flow diverter intended for the treatment of intracranial aneurysms—heralds the “next evolution” in these types of neurovascular devices.
That is according to J Mocco (Mount Sinai, New York, USA), who spoke to...
Boston Scientific has announced that the US Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter Alpha spinal cord stimulator (SCS) systems for the treatment of painful diabetic peripheral neuropathy (DPN), a complication of diabetes...
Brainomix and Nanoflex Robotics have announced today that they have been awarded a grant via the ‘UK—Switzerland Bilateral: Collaborative R&D ’ programme, under which the companies will work together to jointly develop an integrated remote diagnosis and treatment platform...
While sex disparities regarding the outcomes of carotid revascularisation have “long been a concern”, new prospective data published in the Journal of Vascular Surgery (JVS) indicate that no such disparity exists between male and female patients treated with transcarotid...
NeuraSignal has announced the publication of positive results from the BUBL clinical study supporting the safety and superior performance of its NovaGuide intelligent ultrasound system in detecting right-to-left shunt (RLS)—often due to a patent foramen ovale (PFO)—in patients with...
Royal Philips and the World Stroke Organization (WSO) have announced the signing of a two-year partnership aimed at improving access to high-quality stroke care.
Building on their shared commitment to delivering improvements in stroke prevention, treatment, rehabilitation and support, Philips...
Hyperfine has announced US Food and Drug Administration (FDA) clearance of updated software for its portable magnetic resonance brain imaging technology, the Swoop system.
Built on a “robust” artificial intelligence (AI) foundation, the latest software brings image-quality enhancements to...
Between now and 2050—unless “urgent action is taken”—the number of people who die from stroke globally is estimated to increase by 50%, to 9.7 million deaths per year, with annual costs as high as US$2.3 trillion also a possibility....
Roger Malcolm Greenhalgh, the surgeon internationally renowned for his unparalleled contribution to vascular education, training and research, died peacefully on 6th October, aged 82. At the time of his death, he was emeritus Professor of Surgery at Imperial College...
Contego Medical has announced enrolment of the first patient in the prospective, multicentre PERFORMANCE III trial aimed at further evaluating the safety and effectiveness of the Neuroguard integrated embolic protection (IEP) direct system—a carotid stent system designed for direct transcarotid...
Exclusive interviews with multiple pioneering figures in the US neurovascular field earmark NeuroNews’ latest top 10, as do results from two ongoing studies attempting to elucidate mechanical thrombectomy and its place alongside other therapies in acute ischaemic stroke. A...
Biotronik Neuro has announced that results from the BENEFIT-02 trial—the “first of its kind” to clinically evaluate a multiphase stimulation paradigm—support the effectiveness of RESONANCE multiphase stimulation used in the company’s Prospera spinal cord stimulation (SCS) system for the...
A study recently published in the journal Neurology investigated whether there are discrepancies in the prognosis of subarachnoid haemorrhage (SAH) patients between the university hospital districts in Finland—and has revealed “surprising” regional differences, according to lead author Aleksanteri Asikainen (University...
Medtronic has shared that Paolo Di Vincenzo will join the company as president of its neuromodulation business, effective 30 October 2023. In this role, Di Vincenzo will be responsible for the overall strategic direction of the Medtronic neuromodulation business...
The North American Neuromodulation Society (NANS) has led a multi-society response to the Washington State Health Care Authority (WSHCA) following its review of the current evidence on spinal cord stimulation (SCS).
As per a NANS press release, the state of...
Transradial access, whereby the vasculature is navigated to via the radial artery in the wrist, has been a topic of much debate in the neurovascular space over the past few years. Despite demonstrating promising advantages and being advocated for...
A new study has shed fresh light on the potential connection between pre-existing heart issues and symptoms of ‘long-COVID’. According to researchers from New York University (NYU) Langone Health in New York City, USA, being infected with the pandemic...
This advertorial, intended for US readers only, is sponsored by CERENOVUS.
“Going distally with guide catheters is more routine nowadays,” says Violiza Inoa (Memphis, USA), discussing what she sees as a relatively recent shift in the way many physicians choose...
A young neurosurgeon and researcher from Buffalo, USA has been awarded US$150,000 via the Congress of Neurological Surgeons (CNS) Foundation/Cerebrovascular (CV) Young Investigator Grant to study the reasons why women develop a higher rate of cerebral aneurysms compared to...
Remote teleproctoring has demonstrated promising results in providing hands-on mechanical thrombectomy training and overcoming wartime migration restrictions in Ukraine, according to initial experiences published recently in the journal Interventional Neuroradiology.
“Teleproctoring brings together specialists who are engaged in INR all around the...
Highlights:
New data that "refute" the seminal ARUBA trial's conclusions on interventional treatments for arteriovenous malformations (AVMs) as well as several other highlights from this year's Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA)
...
Highlights:
New data that "refute" the seminal ARUBA trial's conclusions on interventional treatments for arteriovenous malformations (AVMs) as well as several other highlights from this year's Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA)
...
“The possibility to restore mobility to patients could have tremendous benefits,” says Mitchell Elkind, chief clinical science officer of the American Heart Association (AHA), and a tenured professor of neurology and epidemiology at Columbia University (New York City, USA),...
Cerevasc has announced that data from clinical studies examining the use of its eShunt system to treat elderly patients with normal-pressure hydrocephalus, and patients with communicating hydrocephalus following treatment for a ruptured cerebral aneurysm, were recently presented at the Congress...
Saluda Medical has announced that the US Food and Drug Administration (FDA) has approved magnetic resonance imaging (MRI) conditional labelling for its Evoke system, which the company claims is “the first and only” precision, dose-control spinal cord stimulation (SCS)...
Onward Medical has today announced the successful first-in-human implant of its ARC-IM stimulator intended to restore upper-extremity function after spinal cord injury (SCI). The implanted patient also received a wireless brain-computer interface (BCI) designed to initiate thought-driven movement when...
The Brain Aneurysm Foundation (BAF) has announced the recipients of its 2023 research grants, providing support to academic researchers studying the underlying biology of aneurysms or developing new treatment methods.
This year's grantees include leading academic researchers from across the USA and Canada whose...
New data from an analysis of patients who would have been eligible for the ARUBA trial—which previously indicated medical management is likely favourable over intervention in unruptured arteriovenous malformation (AVM) treatment—have produced results contradicting this seminal study, and look...
Data from the US Vascular Quality Initiative (VQI) have indicated that younger patients (aged ≤55 years) who undergo a carotid endarterectomy (CEA) procedure face an increased likelihood of carotid disease recurrence and late neurological events, as compared to their older...
Cerevasc has announced that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) supplement to permit the expansion of a study of its eShunt system in patients with normal-pressure hydrocephalus (NPH) to additional study...
Vesalio has announced the recent presentation of key findings from the CLEAR study—a prospective, multicentre, open-label, single-arm, US Food and Drug Administration (FDA)-regulated investigational device exemption (IDE) trial evaluating the safety and effectiveness of the company’s Neva thrombectomy device,...
Given the potentially devastating consequences that can occur if an ischaemic stroke or acute intracranial aneurysm procedure goes wrong, an interventional neuroradiologist’s practice is inherently pressurised and extraordinarily demanding—even relative to the average physician. To gain insights on how...
Nevro Corporation has announced the publication of new data validating the health economic benefits of 10kHz therapy, the company’s proprietary, high-frequency spinal cord stimulation (SCS) therapy, in both painful diabetic neuropathy (PDN) and non-surgical refractory back pain (NSRBP). These...
Microvention, a wholly owned subsidiary of Terumo Corporation, announced today that the Sofia EX 5Fr 115cm intracranial support catheter received US Food and Drug Administration (FDA) 510(k) clearance on 15 September 2023 for use in transradial access in addition...
Sheba Medical Center in Tel Aviv, Israel has revealed the results from a “groundbreaking” study in the International Journal of Emergency Medicine, validating an artificial intelligence (AI) algorithm developed by Aidoc for intracerebral haemorrhage (ICH) detection.
The study demonstrated that machine...
To help “close the gap between knowledge and action”, the American Stroke Association (ASA) is launching a culturally relevant Spanish-language campaign named ‘Juntos Contra el Derrame Cerebral’ to raise awareness among Spanish-dominant audiences around the use and understanding of...
Motif Neurotech, a company developing minimally invasive bioelectronics for mental health conditions, has announced new research published to the preprint server Medrxiv that demonstrates the use of a millimetre-sized brain stimulator—the prototype Motif DOT microstimulator—in a human subject.
The study was a...
Route 92 Medical has announced the appointment of Jonathan Kennedy to the role of chief financial officer. In this role, Kennedy will be responsible for overseeing all financial management for the company, reporting directly to CEO and founder Tony...
Boston Scientific Corporation has today announced it has entered into a definitive agreement to acquire Relievant Medsystems—a privately held medical technology company that has developed and commercialised the Intracept intraosseous nerve ablation system to treat a form of chronic...
Cerevasc has today announced that findings from a clinical study examining the use of its eShunt system to treat communicating hydrocephalus were recently presented at the 2023 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille,...
Theranica has announced the results of a study, recently published in the journal Pain Management, suggesting the rapid impact of Nerivio—the first and only migraine ‘neuroband’, according to the company—in reducing numbers of migraine days.
A previous study had already...
The Congress of Neurological Surgeons (CNS) Foundation has launched its Pathway to Neurosurgery programme, an initiative dedicated to alleviating healthcare disparities by encouraging high school students from underrepresented groups to pursue a career in neurosurgery or medicine.
"This unique programme...
The Brain Aneurysm Foundation (BAF) has announced the launch of ‘Stop the Pop’—a new campaign intended to increase awareness of the prevalence and impact of brain aneurysms, and the need for ongoing investment to fund new innovations, screening, and...
Several presentations and news stories from this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) ended up among our most-read articles in August. Additionally, exclusive insights on intracranial aneurysm treatments—offered by a globally...
Synchron has announced completion of patient enrolment in the USA-based COMMAND trial assessing the company’s endovascular brain-computer interface (BCI) technology.
“Giving patients the option to receive a BCI device without the need for open brain surgery could open up a...
There are likely to be minimal differences in clinical outcomes between acute stroke patients presenting directly to endovascular treatment centres who undergo mechanical thrombectomy alone, and those who receive intravenous thrombolysis (IVT) plus thrombectomy. That is according to a...
Two separate systematic reviews and meta-analyses—both published recently in Neuromodulation: Technology at the Neural Interface—have concluded that intrathecal drug delivery (IDD) systems are effective in the management of cancer-related pain, with one report also finding an average reduction in...
When it comes to advising young physicians on how to navigate the more commercial, industry-entwined commitments that their career will most likely bring further down the line, there are few better-placed physicians than Ajay Wakhloo (Burlington, USA)—an interventional neuroradiologist-turned-inventor...
This advertorial, intended for readers outside the USA only, is sponsored by Penumbra.
Much of the clinical success that can be achieved with aspiration-based mechanical thrombectomy is dependent on the characteristics and features of the specific device being used. In...
This advertorial is sponsored by Medtronic.
Alberto Nania (National Health Service Lothian, Edinburgh, UK) speaks to NeuroNews to outline how, despite the rapid proliferation of new technologies and clinical data in the interventional neuroradiology (INR) space over the past...
Female representation in the neurointerventional world may be growing, but Johanna Fifi (Mount Sinai, New York, USA) and Anne-Christine Januel (Toulouse University Hospital, Toulouse, France) believe much more work can—and will—be done to carry this even further in the...
Endovascular therapy (EVT) treatments that achieve poor reperfusion have been found to result in inferior clinical outcomes compared to best medical management (BMM) in large vessel occlusion (LVO) acute ischaemic stroke patients.
That is according to a substudy of the...
Rapid Medical has announced Chinese National Medical Product Administration (NMPA) approval for its adjustable Tigertriever revascularisation device, making it the first device to offer patient-specific solutions for removing blood clots from the brain to advance the treatment of ischaemic...
Having initially sought out a career in plastic surgery, Ameer Hassan (Harlingen, USA) switched gears to interventional neurology in 2005—a change of heart he attributes to his “greatest mentor”—and never looked back. In addition to being triple board-certified in...
Mainstay Medical has announced the completion of enrolment in its RESTORE randomised clinical study of ReActiv8 for the treatment of intractable chronic low back pain. The study is designed to provide a direct comparison to optimised medical management for...
A novel brain stimulation technique called high-definition transcranial infraslow pink noise stimulation (HD-tIPNS) was recently evaluated in a placebo-controlled pilot study, and found to be both safe and feasible in the treatment of chronic tinnitus.
However, writing in the journal...
Brain Navi has announced the demonstration of NaoTrac, a neurosurgical navigation robot, and KrystoLens, a single-use neuro-endoscope, at two upcoming conferences: the Congress of Neurological Surgeons (CNS) annual meeting (9–13 September, Washington DC, USA) and the European Association of Neurosurgical Societies...
Nevro Corporation recently announced the publication of 24-month data from the SENZA painful diabetic neuropathy (PDN) randomised controlled trial (RCT)—the largest RCT to evaluate spinal cord stimulation (SCS) as a PDN treatment, the company claims—in Diabetes Research and Clinical Practice.
Published...
Protembis has announced the appointment of J Mocco (Icahn School of Medicine at Mount Sinai, New York, USA) as an independent member of its board of directors.
Mocco will offer insights into the strategic direction of the company as well...
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has designated three new approved bodies to increase the country’s capacity to certify medical devices.
TÜV SÜD, Intertek, and TÜV Rheinland UK join the four current UK approved bodies, almost doubling...
Mahesh Jayaraman, an interventional neuroradiologist at Rhode Island Hospital in Providence, USA—who has led national efforts to improve stroke systems of care in the USA—has been named the 2023 president of the Society of NeuroInterventional Surgery (SNIS), a scientific...
Medtronic has received CE-mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator in the treatment of chronic pain.
Inceptiv is the first Medtronic spinal cord stimulation (SCS) device to offer a closed-loop feature that senses each person's unique biological...
NOTE: This video is ONLY available to watch in selected countries and geographies
Much of the clinical success that can be achieved with aspiration-based mechanical thrombectomy is dependent on the characteristics and features of the specific device being used....
A case series conducted by Courtney Ellerbusch (Centura Home Health, Colorado, USA) on multiple sclerosis (MS) patients has found quantitative improvements in strength, spasticity, and range of motion, over a series of 18 treatments with Neubie direct-current neuromuscular electrical...
A collaborative study published in the journal Brain Stimulation has shown that targeted electrical stimulation in epilepsy patients with traumatic brain injury (TBI) can improve memory—more specifically, the recalling of words—by an average of 19%.
Led by Michael Jacob Kahana...
Laurent Pierot’s (Reims University Hospitals, Reims, France) long career in the treatment of intracranial aneurysms predates not only what many consider to be the advent of the interventional neuroradiology (INR) specialty, the ISAT trial, but also the introduction of...
The phenomenon of missing outcome data (MOD) within stroke registries of mechanical thrombectomy cases “is not a rare event and does not occur completely at random”. That is a key concluding message from research carried out and recently published...
Massachusetts patients experiencing stroke could soon have access to refined treatment, triage and transport protocols based on a provision in the US state’s new budget. According to a press release from the Society of NeuroInterventional Surgery (SNIS), the provision...
Nurami Medical, a medical device startup company, has received 510(k) clearance from the US Food and Drug Administration (FDA) for its electrospun nanofibre-based product, ArtiFascia Dura Substitute. US sales of this resorbable dural repair graft will begin in the upcoming...
Hubly Surgical has announced the results from the first peer-reviewed study comparing the safety and efficacy of its recently US Food and Drug Administration (FDA)-cleared portable cranial access drill with smart auto-stop to a well-established, non-portable neurosurgical perforator.
The...
Enspire DBS Therapy has announced the publication of the results of the EDEN trial—an early feasibility study led by Cleveland Clinic (Cleveland, USA) researchers assessing electrical stimulation of the dentate nucleus for upper-extremity hemiparesis due to ischaemic stroke—in Nature Medicine.
The EDEN...
BlueWind Medical has announced that the US Food and Drug Administration (FDA) has granted a de novo marketing request for the Revi system—a “transformative” tibial neuromodulation therapy for the treatment of the symptoms of urgency incontinence alone or in...
Kandu Health has announced preliminary outcomes from the first 40 stroke survivors served by its novel stroke recovery programme, which intends to support stroke patients returning to community settings after hospital discharge.
Preliminary data from the first 40 stroke survivors...
A new study led by researchers from the University of Chicago Medicine (Chicago, USA) has revealed that nearly 75% of acute stroke patients wait more than two hours to be transferred to a comprehensive stroke centre (CSC)—a treatment delay that creates...
Hyperfine has announced completed enrolment for HOPE PMR—a multicentre, observational pilot study assessing portable magnetic resonance imaging (MRI) in children with neurological injury, using hydrocephalus as an index condition.
With the aim of exploring a safer, more accessible solution for...
Flow Neuroscience, the creator of the Flow transcranial direct current stimulation (tDCS) headset for at-home, non-invasive brain stimulation to treat depression, has announced the results of its US Food and Drug Administration (FDA) pivotal clinical trial. The results show...
Imperative Care has announced a new organisational structure designed to accelerate the company’s growth across its businesses. As per an Imperative press release, this new business architecture connects a “continuum of stroke and vascular care” for patients, from onset...
NeuroNews’ 10 most popular stories from July reveal a huge amount of interest in the treatment of stroke patients with medium vessel occlusions (MeVOs)—with the role of mechanical thrombectomy being examined via expert opinion and published research alike. Key...
Saluda Medical has announced the publication of new health economic data in the Clinical Journal of Pain that provides “the strongest ever economic case” for the use of its Evoke closed-loop spinal cord stimulation (SCS) with physiologic SmartLoop technology over open-loop SCS therapy,...
More stroke patients are benefitting from life-changing treatment thanks to Brainomix's e-Stroke artificial intelligence (AI) platform, according to a recent report from the Oxford Academic Health Science Network (AHSN).
Brainomix's e-Stroke imaging technology uses AI to automatically process computed tomography...
A study presented at last week’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August 2023, San Diego, USA) noted that mechanical thrombectomy—in addition to its usage in adults with large vessel occlusion (LVO) stroke—is also safe and...
Using a ‘care hotel’ model, which discharges patients to a specialty hospital hotel after smaller surgeries, can lower costs and shorten patients’ time in the hospital following some elective neuroendovascular interventions. That is according to a study presented recently...
Enspire DBS Therapy recently announced that it has raised US$17.6 million of committed capital in a Series B financing led by existing investor Cleveland Clinic Innovations. Also participating in the round were JobsOhio Growth Capital Fund and an undisclosed investor.
The company...
Anuncia Medical has announced the successful first implant of the company's US Food and Drug Administration (FDA)-cleared ReFlow mini flusher device.
Performed on by neurosurgeon Samuel Cheshier (Intermountain Primary Children's Hospital, Salt Lake City, USA), the patient previously required at least 11...
Imperative Care has announced late-breaking data from the Neurovascular Quality Initiative-Quality Outcome Database (NVQI-QOD) evaluating its Zoom stroke solution, which were presented at the Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August 2023, San Diego, USA) by...
Kernel has unveiled its Flow2 system, which the company claims will give researchers and clinicians “unprecedented access” to robust, functional magnetic resonance imaging (fMRI)-like neuroimaging in a quick and user-friendly headset—making precision neuromedicine “more accessible than ever before”.
Flow2 incorporates...
During a late-breaking abstract session at this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA), researchers discussed a smartphone application that can reliably, autonomously recognise patients’ physical signs of stroke thanks to the...
Contrary to the results of a seminal study in the field, a recent analysis presented at the Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) indicates that surgical approaches—including embolisation, microsurgery and radiosurgery—for treating...
Viz.ai has announced the presentation of three new abstracts that demonstrate the real-world impact of the Viz neuro suite at this week’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA). These independent studies demonstrate...
A study presented yesterday at the Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) indicates that it may be possible to use a less invasive technique to identify the gene mutations responsible for some...
EOSolutions has announced the US Food and Drug Administration (FDA) 510(k) submission, through a design consulting firm, of the Thinline 8Fr sheath—a vascular access solution designed to complement the “remarkable features” of the company’s Dr Banner balloon guide catheter (BGC).
Together,...
Imperative Care has announced multiple new pieces of data from studies evaluating its Zoom stroke solution, presented at the ongoing Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA).
“We are pleased to see the results...
Aidoc has announced the launch of its “revolutionary” Full Brain solution, which the company claims will significantly expand the anatomy analysed by artificial intelligence (AI) to identify suspected strokes, allowing for identification and care coordination of patients with medium...
Research presented at the ongoing Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) has shown that different types of stent-retriever tips may result in improved patient outcomes when performing a mechanical thrombectomy to treat...
Microvention, a wholly owned subsidiary of Terumo Corporation, has announced the publication of five-year follow-up data from the WEB-IT trial and the addition of two sizes to its Woven EndoBridge (WEB) aneurysm embolisation system.
With these now-published five-year clinical trial data,...
A study presented on the first day of the 2023 Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) has found that US rates of endovascular stroke thrombectomy are projected to increase “dramatically” based on...
This advertorial, sponsored by Siemens Healthineers, is intended for US readers only.
A neurosurgical clinic in Raleigh, USA recently opened an office-based lab (OBL)—specifically, the country’s first office-based endovascular neuro practice supported by a fixed biplane angiography system from Siemens...
Administering antiplatelet medication within 24 hours of a mechanical thrombectomy procedure may help stroke patients recover more successfully and prevent high-risk individuals from experiencing additional strokes, according to a study presented yesterday at the Society of NeuroInterventional Surgery (SNIS)...
Route 92 Medical has today announced the publication of a retrospective, first-in-human study featuring its FreeClimb 70 reperfusion system in the journal Interventional Neuroradiology. The study, conducted across five US centres and one international site, reports “impressive” M1 first-pass...
A novel approach to vagus nerve stimulation (VNS) may enable successful post-stroke recovery without the need for “invasive and often-uninsured” traditional VNS therapies.
A paper published in the journal Neurorehabilitation and Neural Repair by Medical University of South Carolina (MUSC) researchers...
Mainstay Medical recently announced the publication of three-year clinical data from the post-market clinical follow-up (PMCF) study of 33 ReActiv8 patients at five medical centres across the UK. ReActiv8 is an implantable medical device designed to treat adults with...
Anuncia Medical has announced the successful US commercial launch of the ReFlow mini flusher—a second-generation device for the treatment of hydrocephalus. According to a company press release, neurosurgeons in the USA and, soon, internationally will now have a new...
In a guest piece for NeuroNews, Thomas Devlin (Chattanooga, USA) and Michelle Luffey advise the community on how best to navigate the transition from primary stroke centres (PSCs) to comprehensive stroke centres (CSCs) and, in doing so, provide stroke...
Nicolab and Titan Neuroscience Research Australia have announced the formal signing of a Memorandum of Understanding (MOU) between the two organisations. The MOU outlines the establishment of a collaborative partnership aimed at leveraging their respective resources and expertise.
This MOU...
Hubly Surgical has successfully closed its Series seed funding round at an oversubscribed US$3 million. As per a company announcement, this investment comes on the heels of a recent US Food and Drug Administration (FDA) clearance for the Hubly Drill—a patented...
Nalu Medical, a company that has miniaturised neurostimulation implants for the management of chronic intractable pain for both peripheral nerve stimulation (PNS) and spinal cord stimulation (SCS) indications, presented new data from several studies at the recent American Society...
Imperative Care has announced US Food and Drug Administration (FDA) 510(k) clearance of its Zoom 88 large distal platform (LDP) support, a portfolio expansion of the company’s original Zoom 88 LDP.
In a press release, Imperative claims to have pioneered...
RapidAI today announced US$75 million in Series C funding led by Vista Credit Partners, a subsidiary of Vista Equity Partners and strategic financing partner focused on the enterprise software, data and technology markets.
A press release details that the funding aims to...
Arsenal Medical has today announced enrolment of the first patient treated with the company’s investigational NeoCast embolic biomaterial for neurovascular conditions.
The patient was successfully embolised as part of the NeoCast first-in-human clinical trial—an open-label, multicentre study evaluating the early...
iVascular has announced that the SEMTIC study, evaluating the safety and efficacy of its comprehensive stroke thrombectomy treatment, is one step closer to providing its first outcome data, with more than 50% of patients having now been enrolled.
The primary...
When utilised as a first-line technique for medium vessel occlusion (MeVO) stroke, aspiration and stent-retriever thrombectomy have demonstrated “no significant difference” in imaging-related or clinical outcomes. That is according to a multicentre, propensity score-matched analysis including more than 400...
Insightec has announced US Food and Drug Administration (FDA) approval of the five-year study endpoint for what it claims is the largest prospective, long-term follow-up study of unilateral magnetic resonance-guided focused ultrasound (MRgFUS) surgery, or ‘thalamotomy’, for essential tremor...
Magnus Medical has announced that the first participants have been treated in the Open Label Optimisation (OLO) clinical trial evaluating the effectiveness of the company’s neuromodulation system with SAINT technology for the treatment of major depressive disorder (MDD).
“SAINT therapy...
Experts in Germany are working on an ‘intelligent suit’ with which they hope to significantly improve rehabilitation after a serious spinal cord injury. This artificial intelligence (AI)-supported solution will be developed over the next three years by researchers from...
Researchers in Germany have developed a new deep learning model for detecting stroke lesions, claiming that—by leveraging rich geometric information to segment brain stroke lesion images—the proposed approach may be able to outperform other, more widely used neural network...
Neurolief has announced positive results from a planned interim analysis of the ongoing, randomised controlled MOOD pivotal trial, which is studying Relivion DP—a novel neuromodulation therapy for the treatment of major depressive disorder (MDD).
At a meeting of the study's...
Rapid Medical has announced new clinical data demonstrating the “significant advantages” of its novel Comaneci embolisation assist device over established techniques to treat ruptured wide-neck intracranial aneurysms.
A recent meta-analysis published in World Neurosurgery found that Comaneci is associated with...
The concluding findings of a systematic review and meta-analysis published in the journal Neurosurgery indicate that flow-diverter performance in posterior communicating artery (PComA) aneurysms is “comparable” to the outcomes observed in other supraclinoid aneurysm subtypes.
Authors Santiago Ortega-Gutierrez (University of...
Cognito Therapeutics has announced “robust, lobe-specific” changes in white matter volume and myelination in Alzheimer’s disease patients following six months of non-invasive gamma stimulation therapy using its at-home wearable device.
The company presented new imaging data at the 2023 Alzheimer’s...
The neuromodulation space has proliferated significantly over the past few years, and one area in which this is most notable is with the expansion of spinal cord stimulation (SCS)—not only in terms of technological advancements, but also regarding the...
Royal Philips has today announced enrolment of the first patients in both the USA and France into the large-scale WE-TRUST study—a multicentre, prospective randomised controlled trial assessing whether a direct-to-angio-suite (DTAS) workflow improves outcomes for early time-window stroke patients...
Despite having worse stroke symptoms and living within comparable distances to comprehensive stroke centres (CSCs), women with large vessel occlusion (LVO) acute ischaemic stroke are less likely to be routed to these types of centres compared to men, according...
The two prevailing techniques used during surgical treatments of traumatic acute subdural haematomas (SDHs)—craniotomy and decompressive craniectomy—have demonstrated broadly similar efficacy outcomes in a randomised controlled trial (RCT). However, reporting their findings in the New England Journal of Medicine...
Evren Technologies has announced the launch of its Phoenix 100 system, a “state-of-the-art” transcutaneous auricular vagus nerve stimulator (taVNS) research tool.
The Phoenix 100 system is intended to solve longstanding challenges faced by researchers in the realm of VNS, as—according to a...
A US centre has achieved a steep drop in infection rates among its neurosurgery patients over a two-year period thanks to the implementation of a multidisciplinary quality and process improvement initiative—as per a recent presentation at the Association for...
Stryker has commercially launched its Q guidance system with cranial guidance software to provide surgeons with an image-based planning and intraoperative guidance system that assists in positioning instruments and identifying patient anatomy during cranial surgery.
The software can be used...
Engineers at Rice University (Houston, USA) have created nanoelectrodes that are minimally invasive and exceptionally flexible—and, as such, have the potential to function as an implanted platform, enabling long-term, high-resolution neurostimulation therapy.
As per a statement from Rice University, traditional,...
Hyperfine, the company that created the Swoop system—which it claims is the world’s first US Food and Drug Administration (FDA)-cleared portable magnetic resonance (MR) brain imaging system—has today announced the commencement of the ACTION PMR study.
To support its acute stroke care...
With multiple large clinical trials currently underway to assess thrombectomy treatments in patients with medium vessel occlusion (MeVO) stroke, Johanna Ospel (Calgary, Canada) takes a look at the possibility of endovascular therapy (EVT) becoming the standard of care for...
ZAP Surgical Systems has announced that the company has received National Medical Products Administration (NMPA) approval in China for its ZAP-X gyroscopic radiosurgery platform.
ZAP-X was previously granted NMPA’s Chinese Medical Device Evaluation (CMDE) green pathway, an accelerated path for...
Zeta Surgical has successfully treated its first patient using the Zeta cranial navigation system as part of a first-in-human trial at the National Neuroscience Institute (NNI) in Singapore.
The clinical trial at NNI aims to evaluate the safety, efficacy and feasibility of...
Append Medical has raised US$4.35 million as part of an extended series A round, which will be used to support the company's first-in-human trials of Appligator.
Investors include participants from the first tranche of the series A round, as well as new investors,...
The results of a clinical trial have shown that a drug commonly used for patients with bleeding disorders has the potential to lessen the side-effects of blood-thinning drugs in stroke patients.
Researchers from the University of Nottingham (Nottingham, UK) and...
Highly targeted electrical stimulation to the brain has shown promise as a treatment option for acute ischaemic stroke, according to a pilot study led by University of California Los Angeles (UCLA) Health researchers in Los Angeles, USA.
The study is the first...
In addition to a number of key study presentations from the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany), NeuroNews’ most popular stories from June include pain physicians’ response to a recent review of spinal cord stimulation (SCS)...
MindRhythm, in partnership with Wayne State University School of Medicine (Detroit, USA), recently announced that the first patient has been enrolled in the pivotal portion of its EPISODE-VS study—which is designed to validate that use of the company’s proprietary...
Researchers at the RIKEN Center for Brain Science (CBS) in Wako, Japan have discovered a set of related mutations that lead to intracranial aneurysms. The mutations all appear to act on the same biological signalling pathway, and—writing in the...
Theranica has announced the results of a study recently published in the journal Headache demonstrating the safety of its Nerivio device—a novel remote electrical neuromodulation (REN) wearable—as a drug-free treatment for pregnant women with migraine.
The study found no statistically...
Neuroprotective agents and steerable microcatheter technologies were among a number of potential new interventional neuroradiology (INR) frontiers showcased and discussed at this year’s LINNC Paris Course (5–7 June 2023, Paris, France)—with faculty member Ricardo Hanel (University of Florida, Jacksonville,...
SynerFuse has announced that—for the first time in the world, it claims—a solo spine surgeon has performed the SynerFuse procedure in a two-level spinal fusion patient.
Rohan Lall (M Health Fairview, Minneapolis, USA) performed the procedure and implanted a neurostimulator...
Just two months after announcing what it claims is the “world's first positive surgical trial” in haemorrhagic stroke, NICO Corporation is awarding a US$200,000 investigator-initiated study grant with the goal of building on conclusions from the ENRICH study and...
Microvention, a wholly owned subsidiary of Terumo, has announced that the ERIC retrieval device is now commercially available in the USA for ischaemic stroke treatment, having received 510(k) clearance from the US Food and Drug Administration (FDA) on 31 March 2022.
"The...
A new study from Keck Medicine at the University of Southern California (USC; Los Angeles, USA) has uncovered “significant racial disparities” in the diagnosis, treatment and outcomes of peripheral artery disease (PAD) among Black and white patients in the USA.
“We discovered that Black...
InspireMD today announced that it has completed enrolment of its ongoing C-Guardians US Investigational Device Exemption (IDE) clinical trial, designed to support potential US marketing approval of its CGuard Prime embolic prevention stent (EPS) system.
The C-Guardians clinical trial is...
Expert groups from the USA and China have separately introduced new guidelines relating to the management of aneurysmal subarachnoid haemorrhage (aSAH). The updated guidelines—spearheaded by the American Heart Association/American Stroke Association (AHA/ASA)—are intended to provide “patient-centric recommendations for clinicians...
LivaNova has announced that the 150th bipolar depression patient has been randomised in its RECOVER clinical study—a prospective, multicentre, double-blinded randomised controlled trial investigating the safety and effectiveness of the company’s vagus nerve stimulation (VNS) therapy system as an...
As president of the Society of NeuroInterventional Surgery (SNIS), endovascular neurosurgeon J Mocco (Icahn School of Medicine at Mount Sinai, New York, USA) has aspired to take the baton from his predecessors and carry forward their work in improving...
Alessandro Gregio (University of Bologna, Bologna, Italy) recently presented midterm results from the Carotid asymptomatic stenosis observational study during the first of two Society of Vascular Surgery-Vascular and Endovascular Surgery Society (SVS-VESS) scientific sessions on the opening day of...
As per a press release from AptaTargets, JAMA Neurology has published positive results from APRIL—a Phase 1b/2a clinical trial evaluating the safety and efficacy of the neuroprotective drug ApTOLL in combination with endovascular therapy (EVT) in patients with acute...
Pain physicians have urged the Cochrane Library to retract and revise a recent review of spinal cord stimulation (SCS) in the treatment of low back pain, citing “striking errors” across the publication’s methodology, executions and conclusions.
Writing in the Cochrane...
Sensome and Asahi Intecc have today announced a collaboration to develop the next-generation Clotild smart guidewire, with Asahi Intecc taking on the manufacturing role for this artificial intelligence (AI)-powered device intended for the treatment of acute ischaemic stroke.
As a...
Transient ischaemic attacks (TIAs) encountered with incomplete neurovascular imaging in emergency departments (EDs) have been associated with higher odds of subsequent stroke within 90 days, as per a publication in the American Journal of Roentgenology (AJR).
“Increased access to urgent neurovascular...
Imperative Care recently announced the appointment of Kirsten Carroll as the new CEO of Kandu Health—a digital health startup with the aim of improving quality of life for people affected by stroke. The company has also announced the successful enrolment...
A prospective study has demonstrated that carotid intervention can improve mood in depressed patients with advanced carotid disease, in addition to enabling cognitive improvements irrespective of baseline depression.
These findings were presented at the Vascular Annual Meeting (VAM; 14–17 June,...
A durability study that looks at reintervention risk among patients treated with carotid endarterectomy (CEA) versus carotid artery stenting (CAS) procedures established that CEA demonstrated the lowest risk up to six months after surgery. A subgroup analysis between stenting...
Findings that consider the incidence of carotid stent fractures and their impact on stent durability were elucidated by Neeta Karani (Bronson Healthcare, Kalamazoo, USA) during a plenary session at this week's Vascular Annual Meeting (VAM; 14–17 June 2023, National...
A study presented recently at the Vascular Annual Meeting (VAM; 14–17 June, National Harbor, USA) has found that the long-term outcomes of transcarotid artery revascularisation (TCAR) are “not significantly affected” by prior head and neck radiation. Owing to substantially...
Earlier this year, researchers debuted single-centre experiences indicating that intravascular lithotripsy (IVL) may be able to expand transcarotid artery revascularisation (TCAR) into patients with traditionally prohibitive calcific disease. With a multicentre case series now further suggesting IVL’s utility, but...
Royal Philips has today announced the results of a health economics analysis published in the Journal of NeuroInterventional Surgery (JNIS) that show an “innovative approach” to the stroke care pathway—referred to as direct-to-angio suite (DTAS)—can reduce costs by an average of €2,848...
A multicentre study presented at the recent European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has found that vision recovery and an increased likelihood of early neurological improvement are among the potential benefits endovascular therapy (EVT) can offer...
A new study conducted by scientists at Louisiana State University (LSU) Health New Orleans Neuroscience Center of Excellence (New Orleans, USA) reports that the additive neuroprotection of a combination of two omega-3 fatty acid-derived signalling molecules is more effective...
By identifying plasma proteomic determinants of incident cardioembolic and non-cardioembolic ischaemic stroke, researchers in the USA have found a novel protein believed to be associated with stroke risk in patients with left atrial dysfunction.
Detailing findings from the Cardiovascular Health...
Imperative Care has announced the publication of early clinical data in the Journal of NeuroInterventional Surgery (JNIS) from a single-centre evaluation of the Zoom RDL radial access system.
This independent, retrospective evaluation of Zoom RDL in 29 patients—who underwent neurointerventional procedures from...
Precision Neuroscience Corporation has announced that the first in-human procedures in a pilot clinical study of its neural implant system have been successfully completed. In partnership with West Virginia University Rockefeller Neuroscience Institute (WVU RNI; Morgantown, USA), this study...
Presenting first-time data from large multicentre European studies at this year's Leipzig Interventional Course (LINC 2023; 6–9 June, Leipzig, Germany), Arne Schwindt (St Franziskus Hospital Münster, Münster, Germany) and Ralf Langhoff (Sankt Gertrauden Hospital, Berlin, Germany) delivered results that...
The US Food and Drug Administration (FDA) has released draft guidance with updated recommendations for good clinical practices (GCPs) aimed at modernising the design and conduct of clinical trials.
In a statement, the regulator said that the updates are intended...
Neuralace Medical has announced the upcoming clinical study presentation of the SEAT randomised controlled trial (RCT), which is assessing the safety and efficacy of its Axon therapy, at the American Society of Pain and Neuroscience (ASPN) conference (13–16 July, Miami, USA).
Leonardo...
While the exact location of atherosclerotic plaque ruptures—a common cause of myocardial infarction (MI) and stroke—has previously been unknown, researchers at Lund University (Lund, Sweden) have now managed to successfully map this phenomenon. In addition, the team has identified...
While a handful of our highlights from the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) unsurprisingly feature in NeuroNews’ most-read stories through the month, key industry updates and a closer look at how ChatGPT (Open AI) may...
The MAGNA meta-analysis of individual patient data (IPD) has provided “strong, generalisable evidence” on the clinically meaningful benefits of endovascular therapy (EVT) in ischaemic stroke patients with a large-core infarct volume. Late-breaking findings from MAGNA were presented by Amrou...
At a time when many of Europe’s medical technology markets are effectively going backwards due to complications created by the EU Medical Device Regulation (MDR), corresponding sectors in the USA are receiving an inevitable boost. Alongside the US Food...
Anuncia Medical has announced that an article highlighting its US Food and Drug Administration (FDA)-cleared and CE-marked ReFlow ventricular system (Gen 1) with hydrocephalus shunts in patients suffering from chronic shunt occlusions has been published in Pediatric Neurosurgery.
Two years prior...
Nalu Medical has announced the first patient enrolment in the COMFORT-2 randomised controlled trial (RCT), which will assess the company’s peripheral nerve stimulation (PNS) technologies. Together with COMFORT-1, COMFORT-2 is designed to enrol the largest cohort of RCT subjects...
New data from the VECTOR randomised controlled trial—presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany)—have indicated that a mechanical thrombectomy in which a stent retriever is deployed alongside contact aspiration, a 'combined technique', is not...
Highlights:
Positive results with the Woven EndoBridge (WEB; Microvention/Terumo Corporation) device—presented for the first time at the LINNC Americas Seminar (16–17 March, Miami, USA)—indicate its utility across a range of intracranial aneurysm types
Our very own editor-in-chief, Philip M...
Highlights:
Positive results with the Woven EndoBridge (WEB; Microvention/Terumo Corporation) device—presented for the first time at the LINNC Americas Seminar (16–17 March, Miami, USA)—indicate its utility across a range of intracranial aneurysm types
Our very own editor-in-chief, Philip M...
The results of the TESLA trial were recently presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany), demonstrating a “strong suggestion” across several domains that endovascular therapy (EVT) can provide benefits over best medical management (BMM)...
Penumbra has announced the US Food and Drug Administration (FDA) clearance and launch of Lightning Bolt 7, which the company claims is the most advanced and powerful arterial thrombectomy system on the market.
Lightning Bolt 7 introduces a new method...
Adept Medical has announced the launch of the Head Immobiliser—a radiolucent support for a range of interventional radiology (IR) and neuroradiology procedures. Now commercially available, the positioning device can help mitigate the costs of retakes, from reducing the amount...
Following the presentation of new trials assessing intracranial haemorrhage (ICH) treatment approaches, INTERACT3 and ENRICH, Craig Anderson (The George Institute for Global Health, Sydney, Australia)—who delivered first-time data from the former of the two studies—posited that, “maybe, the time...
Stryker has announced that Early Product Surveillance (EPS) cases utilising its Q guidance system with cranial guidance software are underway. The technology provides surgeons with image-based planning and an intraoperative guidance system designed to support cranial surgeries, a company press...
A collaboration analysing several major clinical trials has found that endovascular therapy (EVT) plus intravenous thrombolysis (IVT) is likely to be superior to EVT alone—also known as direct EVT—in the majority of ischaemic stroke patients, but that one of...
Nicolab has been awarded a prestigious three-year contract to supply stroke workflow software and advanced artificial intelligence (AI) diagnostics for the Victorian Stroke Telemedicine (VST) service in Viewbank, Australia.
The VST service—a virtual platform that connects healthcare professionals across multiple...
EOSolutions Corporation has announced the introduction of the Dr Banner balloon guide catheter (BGC), which boasts “unmatched features” for neurovascular procedures. As per a company press release, the device was developed in collaboration with InNeuroCo, and sets “new benchmarks”...
Supplying healthcare providers with performance feedback can significantly reduce the time between an ischaemic stroke patient arriving at a hospital and them subsequently receiving endovascular therapy (EVT), according to the findings of a clinical trial presented at last week’s...
Onward Medical has announced a recent publication in Nature showing that a wireless brain-computer interface (BCI) can use patients’ thoughts to modulate ARC therapy. Researchers reported that, when paired with the company’s ARC therapy, an implanted BCI allowed an...
Positive results from a clinical trial involving a novel therapeutic procedure known as sonolysis—deployed during a carotid endarterectomy (CEA)—were presented at the recent European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany).
“The randomised clinical trial confirmed the results of...
NeuroOne Medical Technologies has announced the first clinical case using the Evo stereoelectroencephalography (sEEG) electrode in robotic neurosurgery.
Performed by William Bingaman at Cleveland Clinic in Cleveland, USA, the procedure was the first to utilise NeuroOne’s Evo sEEG electrode—exclusively marketed in the...
A retrospective study from China has concluded that the Pipeline Flex embolisation device (Medtronic) is safe and effective in the treatment of complex intracranial aneurysms. Reporting their results in Nature: Scientific Reports, Shun-Qiang Chen (Henan Provincial People's Hospital, Zhengzhou,...
Artiria Medical, a Swiss neurovascular company, has announced that its real-time, deflectable guidewire has been granted 510(k) clearance by the US Food and Drug Administration (FDA).
This milestone opens a “new pathway” to a “more advanced and effective approach”...
Interim results from the ECST-2 randomised controlled trial (RCT) have shown no evidence that carotid stenosis patients with a low-to-intermediate stroke risk, treated with optimised medical therapy, will benefit from additional carotid revascularisation via carotid endarterectomy (CEA) or carotid...
Results from the TIMELESS trial represent “fantastic news” on the safety of intravenous tenecteplase in selected late-window stroke patients, despite the drug failing to meet its prespecified primary and secondary efficacy endpoints.
That is according to Gregory Albers (Stanford...
While patients treated via a structured ambulatory post-stroke care programme (SANO) in a recent cluster-randomised study experienced better control of their cardiovascular risk factors compared to a control group, this did not translate into any significant reduction in recurrent...
In an attempt to promote more consistent and higher quality research in the field of small vessel disease (SVD), international experts have published the second iteration of the Standards for Reporting Vascular Changes on Neuroimaging (STRIVE-2)—an update to the...
As per results from the RESIST study, remote ischaemic conditioning (RIC)—while not being associated with any major safety issues—has failed to improve functional outcomes in patients with acute ischaemic stroke.
These findings were presented today at the European Stroke Organisation...
An international clinical trial presented today at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has demonstrated that—in people with ischaemic stroke and atrial fibrillation—anticoagulation can safely be started earlier than current guidelines recommend.
"Our study finally brings...
A team of researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by human emergency call handlers. The framework outperformed emergency call handlers in recognising stroke for both...
The Woven EndoBridge (WEB) 17 device (Microvention/Terumo Corporation) has demonstrated positive efficacy and safety outcomes in the prospective, multicentre CLEVER study, indicating its utility for intrasaccular embolisation across ruptured and unruptured intracranial aneurysms. Twelve-month results from the study were...
A new randomised controlled trial (RCT)—the “largest ever” of its kind in the major depressive disorder (MDD) space—will attempt to provide a “thorough understanding” of how treatment-resistant patients respond to vagus nerve stimulation (VNS) therapy.
Details of the RECOVER trial...
Both open and endovascular surgical approaches are likely to produce improved outcomes compared to ligation in the treatment of ruptured extracranial carotid artery aneurysms. This was the salient point delivered by Maarit Venermo (Helsinki University Hospital, Helsinki, Finland) at the...
An analysis published in the Journal of Neurosurgery, which assessed ChatGPT’s (OpenAI) performance on a surrogate for neurosurgical board-style questions, has found that the natural language processing (NLP) algorithm was able to significantly outperform medical students and was only...
Abbott has announced that the US Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of chronic back pain in people who have not had or are not eligible to receive back...
‘Upstream’ causes of health inequities related to stroke—such as structural racism and conditions of the places where people live, learn, work and play—have not been studied well, according to a recent American Heart Association (AHA) scientific statement. The statement,...
RapidAI announced recently that its combined haemorrhagic solution—Rapid ICH (intracranial haemorrhage) and Rapid Hyperdensity—has been selected as the “Best New Imaging Solution” in the seventh annual MedTech Breakthrough Awards, which attracted more than 4,000 nominations from over 17 countries this...
Magnus Medical has shared promising results from a clinical trial published in the Proceedings of the National Academy of Sciences indicating that treatment with SAINT neuromodulation reverses abnormal brain signalling by changing the direction of brain signal flow in people with...
A nationwide cohort study of over 9,000 patients shows that the “controversial” practice of arteriotomy closure for carotid endarterectomy (CEA) is associated with an increased risk of ipsilateral stroke and “should be avoided”. Instead, authors Magnus Jonsson (Karolinska University...
As per a recently published retrospective chart review, the removal of sacral neuromodulation (SNM) devices in the office setting, under local anaesthesia, is a safe, well-tolerated and effective procedure.
Reporting their findings in the journal Urology, Sarah Martin and Howard...
Carthera has announced the publication in The Lancet Oncology of results from a Phase 1 clinical trial carried out by scientists at Northwestern University Feinberg School of Medicine (Chicago, USA). In the trial, they used the SonoCloud-9 implantable ultrasound...
Endovascular therapy (EVT) has been deemed safe and effective in patients with ischaemic stroke caused by an anterior circulation large-vessel occlusion (LVO) who present 6–24 hours from onset, or last seen well, who were selected on the basis of...
Abbott has announced that the US Food and Drug Administration (FDA) has approved expanded magnetic resonance imaging (MRI) labelling for its Eterna spinal cord stimulation (SCS) system to include new leads that are MR conditional—meaning people with chronic pain...
Earlier this week, the European Academy of Neurology (EAN) announced the launch of the Brain Health Mission, a collaborative initiative that aims to address the global crisis of brain disorders and present solutions.
The mission brings together governments, healthcare providers,...
“Overall, we just need better tools” was one of the salient points delivered by Jane Khalife (Cooper University Health Care, Camden, USA) in a talk at the LINNC Americas Seminar (16–17 March, Miami, USA) focusing on stroke cases with...
Hubly Surgical has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Hubly Drill, which the company describes as an innovative medical technology developed with the goal of making burr-hole procedures safer and more efficient in...
The Get Ahead of Stroke campaign is launching Survive Stroke Week from 15–21 May—an observance aimed at increasing awareness of stroke symptoms and the importance of calling 911 right away.
The longer a stroke patient’s treatment is delayed, the greater...
This advertorial is sponsored by CERENOVUS.
The EMBOTRAP® family of revascularisation devices (CERENOVUS) is innovative within the stent retriever space due to its differentiated design based on a wealth of clot-science research. As a physician currently using EMBOTRAP in mechanical...
Cerevasc has announced that data on its minimally invasive central nervous system (CNS) delivery system will be presented for the first time at the American Society of Gene and Cell Therapy annual meeting (16–20 May 2023, Los Angeles, USA).
The...
Brian Fiani (Livonia, USA) and Ryan Jarrah (Rochester, USA) take a look at the neurosurgical implications of one of the hottest topics permeating not only the medical industry, but virtually all of society, right now—the natural language processing (NLP)...
A systematic review and analysis published in the journal Interventional Neuroradiology has examined how far along “the right path” management paradigms for persistent primitive trigeminal artery (PPTA) aneurysms currently are—ultimately concluding that, while endovascular techniques in this area are successful, “meticulous”...
ConcertAI's TeraRecon has announced the release of Neuro Suite, its artificial intelligence (AI)-driven clinical suite, which the company claims is purpose-built for disease triage, differential diagnostic insights, and care activation in many neurological disease states—such as neuro-oncology, dementia, multiple...
MIVI Neuroscience has announced that it has completed enrolment in the EVAQ clinical trial to assess the safety and effectiveness of the Q revascularisation system for the treatment of acute ischaemic stroke.
The EVAQ trial has enrolled 121 patients at 17...
“The time has definitely come to look at the evidence, and redo these studies,” posited Alun Davies (Imperial College London, London, UK), putting forward his argument that the NASCET and ECST clinical trials “need to be reconducted” at this...
The Heart and Stroke Foundation, Brain Canada, and the Canadian Stroke Consortium, have announced the recipients of the 2022 Stroke Clinical Research Catalyst grants. The purpose of this programme, as per a joint press release, is to increase the capacity for clinical stroke...
A number of potentially contentious issues caught the eye of our readers in April—including how best to define 'success' in stroke thrombectomy; efforts to expand the range of specialties capable of performing these procedures; and question marks over the...
NeuroOne Medical Technologies has announced the commercial launch of the Evo stereoelectroencephalography (sEEG) electrode product line in the USA.
Zimmer Biomet holds exclusive worldwide distribution rights to NeuroOne’s Evo Cortical and sEEG product lines, and the Evo product line is expected...
Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) have received a US$3.4 million grant from Wellcome to study repetitive transcranial magnetic stimulation (rTMS) and its effects—potentially opening the door for a new, non-pharmacological way to treat major mental health disorders like schizophrenia...
Stryker announced today that it has completed the acquisition of Cerus Endovascular—a medical device company engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms.
Cerus’ CE-marked products, including the Contour neurovascular system and the...
New research has indicated that Mexican Americans have worse outcomes after a stroke than non-Hispanic white Americans.
A recent study, which looked at whether the language Mexican American people speak is linked to how well they recover after a stroke,...
Cerenovus has announced that the new Cerepak detachable coils are now commercially available in the USA, and that the first patient cases have been performed. Cerepak is the latest innovation to join the company’s haemorrhagic stroke portfolio.
The Cerepak detachable...
More than half of all stroke survivors may develop cognitive impairment within a year after their stroke, and one in three are at risk for developing dementia within five years. That is according to a new American Heart Association (AHA) scientific statement...
Having taken place via a virtual format in 2021, and as a hybrid meeting last year, the 2023 European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) is set to return to a more traditional, fully on-site setup. Robin...
SynerFuse has announced that Michael Park (University of Minnesota, Minneapolis, USA)—principal investigator for the company’s investigational device exemption (IDE) proof-of-concept study—presented data from the study’s first eight patients at the 10th annual Minnesota Neuromodulation Symposium (20–21 April, Minneapolis, USA).
"This presentation showcased the...
A debate between two prominent carotid interventionists—Peter Schneider (University of California San Francisco, San Francisco, USA) and Domenico Valenti (King's College London, London, UK)—on the Wednesday of the Charing Cross (CX) symposium (25–27 April 2023, London, UK) revealed that...
Penumbra recently announced the launch of the latest addition to its RED family of catheter devices for mechanical thrombectomy, the RED 43 reperfusion catheter.
According to the company, this device is intended to take distal aspiration “to the next level”...
NICO Corporation has announced initial positive results from the completed ENRICH trial at the 2023 American Association of Neurological Surgeons (AANS) annual scientific meeting (21–24 April, Los Angeles, USA). ENRICH was designed to evaluate the safety, efficacy, and economic outcomes...
Route 92 Medical has today announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its FreeClimb 70 reperfusion system, which includes the FreeClimb 70 aspiration catheter along with the Tenzing 7 delivery catheter.
The FreeClimb...
Biotronik has announced US Food and Drug Administration (FDA) approval for Prospera—a new spinal cord stimulation (SCS) system. The system features RESONANCE, which the company claims is the first and only multiphase stimulation paradigm, paired with Embrace One, which...
Cercare Medical has announced it will be bringing its neurovascular clinical workflows into ConcertAI's TeraRecon Eureka clinical artificial intelligence (AI) platform as part of a new partnership.
The platform is intended to provide clinicians with state-of-the-art AI and deep learning technologies, delivering...
NICO Corporation has announced that the results from the completed ENRICH trial will be presented at the annual American Association of Neurological Surgeons (AANS) meeting (21–24 April 2023, Los Angeles, USA).
The ENRICH results were accepted as a late-breaker and...
RapidAI announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance for Rapid non-contrast computed tomography (NCCT) Stroke, which is intended to support faster treatment and transfer decisions in stroke care.
A company press release describes this...
A new set of guidelines intended to standardise and expand stroke thrombectomy training have been published simultaneously in Europe, in the journal Advances in Interventional Cardiology, and in the USA, in Cardiovascular Revascularization Medicine.
The World Federation for Interventional Stroke...
Theranica recently had the results from a real-world analysis of Nerivio for acute treatment of migraine in adolescents published in the journal Pediatric Neurology. The study demonstrates the ease of use, safety and efficacy of Nerivio—the company’s remote electrical neuromodulation...
A “landmark” paper published in The Lancet Neurology by leaders of the Parkinson's Progression Markers Initiative (PPMI)—a study sponsored by The Michael J Fox Foundation (MJFF) for Parkinson's Research—confirms what the charity describes as “the most significant breakthrough yet” in the...
Jason Pope (Santa Rosa, USA) discusses closed-loop spinal cord stimulation (SCS) and its potential to provide sustained, holistic outcomes for chronic pain patients. In addition to describing these theoretical benefits and the mechanisms of action by which they can...
Lithotripsy may hold the key to enabling more carotid artery disease patients who require calcification treatment to undergo stent placement via a transcarotid artery revascularisation (TCAR) procedure, as per single-centre experiences presented at the recent Society for Clinical Vascular...
Adept Medical has launched the Adducted Arm Scoop—an improved solution for supporting the adducted arms of supine patients during image-guided procedures.
Adept’s new, “extremely durable” Adducted Arm Scoops are purpose-designed, providing security and comfort on narrow imaging tables, as per...
This week, three companies developing novel neuromodulation technologies for use in the treatment of various neurological disorders have each separately announced the receipt of significant financing rounds intended to boost their respective brain stimulation therapies.
Saluda Medical has announced the...
Moderate- to high-quality evidence suggests that specific neuromodulation modalities can provide effective treatments in patients undergoing stroke rehabilitation. As per a systematic review and meta-analysis, these therapeutic approaches are able to improve upper-limb motor function in both acute/subacute and...
Annalise.ai has received US Food and Drug Administration (FDA) 510(k) clearances covering an additional seven findings as part of the company's innovative artificial intelligence (AI)-assisted triage and notification solutions. The clearances, which include a suite of time-sensitive stroke findings...
A recent data presentation has revealed reduced risk of stroke and mortality among transcarotid artery revascularisation (TCAR) patients who receive dual antiplatelet therapy (DAPT), at discharge, as compared to other drug regimens. Researchers believe these findings underscore the importance...
Reach Neuro has been granted a Breakthrough Device designation by the US Food and Drug Administration (FDA) for its Avantis platform, which uses small electrical impulses delivered to the spinal cord to help restore shoulder, arm and hand movement...
Intravenous tenecteplase was associated with a higher rate of intracranial haemorrhage (ICH), as compared to alteplase, in a recent analysis of real-world data from acute ischaemic stroke patients who did not undergo a thrombectomy procedure.
Navpreet Bains (University of Missouri,...
The peer-reviewed journal Pain and Therapy recently published a new study, titled "Reduced pain and improved function following short-term use of non-invasive BioWave high-frequency peripheral nerve stimulation for pain management", authored by Alaa Abd-Elsayed (University of Wisconsin School of Medicine and...
While a number of companies in the neurovascular space have become increasingly focused on the ‘first-pass effect’ in mechanical thrombectomy treatments, many major clinical trials assessing the safety and efficacy of the technique still favour a ‘rule-of-three’ paradigm. And—although...
A nationwide study drawing on data from Swedish patients has indicated that—while the majority of ruptured intracranial aneurysm patients treated with microsurgery experienced favourable outcomes—intraoperative adverse events were associated with an increased risk of unfavourable outcomes.
Writing in the Journal...
A new probe that performs two types of spectroscopy could make deep brain stimulation (DBS) procedures safer and improve success rates by helping doctors more accurately navigate instruments inside the brain in patients with advanced Parkinson’s disease.
The research team...
A unique case presentation at this year’s LINNC Americas Seminar (16–17 March, Miami, USA) saw Rafael de Oliveira Sillero (University of Texas Southwestern Medical Center, Dallas, USA) outline how he treated a child with ischaemic stroke at his centre,...
Astrocyte Pharmaceuticals has announced the initiation of a Phase 1b study of its lead cerebroprotective candidate, AST-004, as an extended infusion in healthy volunteers. This adaptive-design clinical study will be conducted over the next four-to-six months at the QPS...
The Catholic Health Initiatives (CHI) Memorial Stroke and Neuroscience Center has announced its participation in the national research study, BUBL, stating that it was “instrumental” in developing the technology involved—a novel solution intended to better detect a specific cause...
A randomised controlled trial (RCT) involving more than 200 patients has indicated that stent-assisted coiling (SAC) is not superior to coiling alone in unruptured intracranial aneurysm cases with a high risk of recurrence.
Reporting results from the STAT trial in...
In addition to the US approval of a unique neurovascular device, discussions around female physicians in the neurointerventional space; pushback against the European Union’s (EU) recent decision to reclassify non-invasive brain stimulation technologies; and a study elucidating disparities in...
A recently published Cochrane review has concluded that the clinical benefits of spinal cord stimulation (SCS) do not outweigh the risks and costs associated with the approach in patients with low back pain—leading researchers to claim that “there is...
Highlights:
The 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) is punctuated by new data on neuroprotective medications in ischaemic stroke, sparking tempered optimism from delegates
Other late-breaking highlights from ISC 2023 include findings on tenecteplase’s utility versus...
Highlights:
The 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) is punctuated by new data on neuroprotective medications in ischaemic stroke, sparking tempered optimism from delegates
Other late-breaking highlights from ISC 2023 include findings on tenecteplase's utility versus...
The opening statements and presentation of evidence are set for 10am PST today in a lawsuit involving claims that a medical doctor and his corporation retaliated against a former employee, Yamin Shwe, after she refused to be concurrently on-call...
The charity Chest, Heart and Stroke Scotland (CHSS) has voiced support for the Scottish government’s decision to reinstate “vital” funding of thrombectomy services across the country, stating that a “whirlwind two-week campaign” centred around its Thrombectomy for All petition...
Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid artery disease patients who undergo stent placement via a transcarotid artery revascularisation (TCAR) procedure.
This is the...
Q'Apel Medical has been granted a CE mark under the European Medical Device Regulation (MDR) for Walrus, its balloon guide catheter (BGC) product used in the treatment of patients suffering an acute ischaemic stroke.
The Walrus BGC has been...
As medical accolades go, performing the world’s first robot-assisted neurointerventional procedure—a feat that Vitor Mendes Pereira and his team achieved back in 2019—is something any physician would be proud of. But, as a professor of Surgery and Medical Imaging...
Cerevasc has named neurosurgeon Adel Malek as its new chief medical officer. This appointment will allow the company to further accelerate the development and clinical strategy of the eShunt system—a minimally invasive device designed to treat communicating hydrocephalus—according to a press...
A new study found no difference in perioperative outcomes and incidence of adverse events at follow-up after transcarotid artery revascularisation (TCAR) between academic and non-teaching community institutions. Presented at the 2023 winter annual meeting of the Vascular and Endovascular...
The Brain Aneurysm Foundation (BAF), a leading global research and advocacy organisation committed to improving treatment and care for brain aneurysms, has announced the addition of Carolina Maier—vice president of Clinical Affairs at RapidAI—to its board of directors.
“We are beyond thrilled...
Alongside his colleagues at the Barts Health NHS Trust, Levansri Makalanda (London, UK) was responsible for setting up the second ever 24/7 mechanical thrombectomy service for ischaemic stroke in the UK. He recently spoke to NeuroNews to outline how...
A recent addition to Europe’s flow diversion market—the Derivo 2 embolisation device (DED2; Acandis)—has demonstrated promise in a small-scale, multicentre study, providing a safe and effective treatment for both ruptured and unruptured intracranial aneurysms.
Writing in Interventional Neuroradiology, study authors...
Athersys has announced planned amendments to its MASTERS-2 clinical trial protocol following a Type B meeting with the US Food and Drug Administration (FDA). Held on 21 March, the meeting addressed Athersys’ proposed modifications that seek to establish primary...
Brainomix has today announced that its 360 e-ASPECTS tool for stroke has received US Food and Drug Administration (FDA) clearance, enabling the company to deploy its cutting-edge artificial intelligence (AI) imaging platform to stroke centres in the USA.
With deployments...
Synchron has announced that the COMMAND trial assessing its endovascular brain-computer interface (BCI) technology is commencing enrolment at Gates Vascular Institute, a Kaleida Health facility and teaching affiliate of the Jacobs School of Medicine and Biomedical Sciences at the...
In the latter stages of 2022, the Society of NeuroInterventional Surgery (SNIS) released a position statement advocating pregnancy and parental leave policies in neurointerventional surgery, stating a belief that physicians “should not have to choose” between a fulfilling family...
A total of £10 million has been awarded to the Medicines and Healthcare products Regulatory Agency (MHRA)—an executive agency of the UK Department of Health and Social Care (DHSC)—to help bring innovative new medicines and medical technologies to UK...
ObvioHealth and Mi-Helper have announced a partnership to conduct a decentralised clinical trial with a small, non-invasive neuromodulation device for the treatment of migraines. The randomised controlled trial will be fully remote, enabling data capture from home—the setting in which...
NeuroOne Medical Technologies has announced the successful completion of an initial animal implant of its novel, thin-film paddle leads for spinal cord stimulation (SCS). The devices are intended for the treatment of patients with chronic back pain due to...
MindRhythm, in partnership with Wayne State University School of Medicine (Detroit, USA), has announced the first publication of results from its EPISODE-PS trial in the journal Stroke: Vascular and Interventional Neurology.
The EPISODE-PS trial was designed to evaluate the use...
A dystonia patient in Turkey who had been having uncontrollable involuntary contractions in her legs and arms for the past five years recently underwent brain pacemaker surgery—while awake and watching cartoons. The surgery was performed within the Medical Park Hospitals...
Scientia Vascular has announced the US Food and Drug Administration (FDA) 510(k) clearance of the Aristotle Colossus macrowire. The company claims that this device is the only 0.035-inch macrowire currently indicated for neurovascular intracranial use.
Like its predecessors—the Aristotle 18...
Carthera, which develops the Sonocloud—an ultrasound-based medical device used to treat a wide range of brain diseases—has announced today the completion of an end-of-Phase 2 meeting with the US Food and Drug Administration (FDA).
The company presented preclinical and clinical...
The European Society for Brain Stimulation (ESBS) has said it “strongly opposes” the European Union’s (EU) recent decision to reclassify non-invasive brain stimulation (NIBS) technologies as Class III medical devices.
In what ESBS members describe as a “sudden and unwelcome”...
With Brain Awareness Week (13–19 March) approaching, the Get Ahead of Stroke campaign has announced it is debuting new online resources for emergency medical service (EMS) providers, enabling them to assist stroke patients with greater efficiency and ease.
As a...
Distal embolic protection using a filter has been associated with improved transfemoral carotid artery stenting (tfCAS) outcomes in terms of in-hospital stroke and death risks—underpinning current Society for Vascular Surgery (SVS) guidelines recommending routine use of distal embolic protection...
The Society of Vascular and Interventional Neurology (SVIN) has released its first global analysis of access to mechanical thrombectomy for the treatment of large vessel occlusion (LVO) stroke. Findings from MT-GLASS—a study conducted as part of the SVIN Mission...
Neuromod Devices has announced that the US Food and Drug Administration (FDA) has granted de novo approval to Lenire—the first bimodal neuromodulation device of its kind to be approved by the FDA for the treatment of tinnitus, according to a company...
Nevro Corporation announced today that it has now initiated the full US market launch of its HFX iQ spinal cord stimulation (SCS) system, following the completion of a successful limited market release.
"This is an exciting time in spinal cord...
The European Union’s (EU) Council of Ministers has today adopted a resolution to extend the deadline for the certification of medical devices under the Medical Devices Regulation (MDR).
Producers of medical devices will have until 31 December 2027 for higher-risk...
A team from the University of Oklahoma (Norman, USA) has embarked on a five-year research project with the intention of designing a device that can be customised to better treat brain aneurysms.
For the project, researchers are set to use...
Children's Minnesota (Minneapolis, USA) has claimed, in a press release, to have become the first health system in North America to open a paediatric hybrid intraoperative magnetic resonance imaging (iMRI) suite equipped with both moving-scanner and moving-patient MRI technology in the same surgical...
Mainstay Medical has announced the publication of a paper, titled “Effect of Restorative Neurostimulation on Major Drivers of Chronic Low Back Pain Economic Impact", in the journal Neurosurgery. The paper contains a review of patients from the pivotal ReActiv8-B...
Spinal cord stimulation (SCS) therapy has been shown to trigger instant improvements in arm and hand mobility, enabling people affected by moderate-to-severe stroke to perform daily activities more easily, as reported in Nature Medicine by researchers from the University...
Physicians in the USA have published details of—to their knowledge—the “first reported use” of the Indigo aspiration system (Penumbra) to treat cerebral venous sinus thrombosis (CVST) via endovascular thrombectomy. The treated patient underwent successful partial recanalisation of the superior...
Altering the porosity of coiling in the treatment of cerebral aneurysms has been found to have a greater impact on maximum oscillatory shear index (OSI) among male patients, as compared to their female counterparts. This is the key concluding...
Stroke research was the flavour of the month throughout February on NeuroNews, with highlights from the International Stroke Conference (ISC; 8–10 February, Dallas, USA) featuring heavily in our most-read stories. Promising findings on the benefits of neuroprotection in ischaemic...
Theranica has announced that its drug-free Nerivio prescription wearable recently received US Food and Drug Administration (FDA) clearance as a dual-use acute and preventive treatment for migraine with or without aura in people 12 years of age or older....
NovaSignal has today announced the donation of a NovaGuide 2 intelligent ultrasound system to the Jacobs Institute in Buffalo, USA in order to advance stroke research, and use real-time neuromonitoring to detect and help prevent intraprocedural cardiovascular and neurovascular complications...
Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) are microscopically mapping more than 100,000 individual fibres that make up the vagus nerve to determine how they are anatomically connected, and which bodily functions they control, and recently...
Route 92 Medical has today announced the issuance of the company’s 80th global patent for its Monopoint operating platform. Route 92 claims this is “the only neurointervention platform” designed to streamline the delivery of large- and super-bore catheters for...
High-frequency spinal cord stimulation (HF-SCS) for treating chronic refractory low back pain (CRLBP) may be associated with a significant decrease in total healthcare costs, offsetting device acquisition costs within 27 months, according to a recent analysis published in Neuromodulation:...
Methinks has announced receipt of a CE mark for its artificial intelligence (AI)-based medical imaging software, Methinks Stroke Suite, following a milestone year of development progress enabling commercialisation in Europe and assisting in emergency settings for the benefit of acute stroke...
A study intended to examine the impact of different weather conditions and modes of transport on mechanical thrombectomies in stroke patients has found a link between higher temperatures and improved outcomes—whereas daily drizzle was associated with poorer post-thrombectomy outcomes.
As...
The opening day of the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) saw the presentation of findings from an animal-model study that assessed multiple promising neuroprotective agents—with one of these candidates, an intravenous, uric acid infusion, exceeding...
Cognito Therapeutics has announced the first patient enrolment in its US pivotal study, HOPE, which is designed to demonstrate the safety and efficacy of the company’s proprietary, non-invasive stimulation device—CogTx-001—in patients with Alzheimer’s disease.
The HOPE study for Alzheimer’s disease is...
Vesalio has announced the successful initial use of its NeVa VS device in the USA for the treatment of post-aneurysmal subarachnoid haemorrhage (aSAH) cerebral vasospasm.
"We are excited to be the first centre to use the NeVa VS device in...
Incepto, a distributor and co-creator of artificial intelligence (AI) solutions applied to medical imaging, has signed a partnership with Avicenna.AI to enrich its platform with new solutions for neurovascular pathologies like stroke.
All of Avicenna’s AI solutions are CE...
The initial findings from a recent randomised controlled trial (RCT) do not support the addition of extracranial to intracranial (EC-IC) bypass surgery to the current medical management of patients with symptomatic internal carotid artery (ICA) or middle cerebral artery...
CVRx has announced the preliminary topline results of the BEAT-HF (Baroreflex activation therapy for heart failure) postmarket clinical trial.
The BEAT-HF postmarket phase of the multicentre, prospective, randomised controlled trial assessed 323 patients suffering from heart failure with reduced ejection...
A randomised trial has found mechanical thrombectomy procedures performed within 24 hours of symptom onset to be more effective than standard medical care in treating acute ischaemic strokes caused by anterior circulation large vessel occlusions (LVOs) with a large...
Brainomix has announced its involvement in a new study sponsored by the University of Liverpool (Liverpool, UK) focused on post-stroke atrial fibrillation (AF). Sites with existing clinical deployments of Brainomix's e-Stroke platform will utilise the artificial intelligence (AI) system...
The favourable trend toward gender parity that has been seen within neurology faculty over the past decade “has not translated” to the leadership of stroke-related clinical trials, as per a recent analysis published in the journal Stroke.
“The results of...
Viz.ai has announced a collaboration with BIOS Clinical Trials Coordinating Center (BIOS CTTC) at Johns Hopkins University (Baltimore, USA) to expedite patient enrolment for the National Institutes of Health (NIH)-funded BEACH study, which is assessing a novel treatment for...
Mechanical thrombectomy appears to be a safe and technically feasible treatment option for ischaemic strokes caused by primary isolated anterior cerebral artery (ACA) occlusions in more distal locations. The procedure—which is more traditionally used in large vessel occlusions (LVOs)...
Among Chinese patients with minor, non-disabling stroke presenting <4.5 hours from symptom onset, dual antiplatelet therapy (DAPT) has been found to be non-inferior to intravenous thrombolysis (IVT) with alteplase regarding 90-day functional outcomes.
Thanh N Nguyen (Boston University Chobanian and...
This advertorial is sponsored by CERENOVUS.
Following the recent addition of the EMBOGUARD balloon guide catheter (BGC) to the CERENOVUS STROKE SOLUTIONSi portfolio of devices, Demetrius K Lopes (Chicago, USA) discusses the significance of this latest tool when it comes...
A randomised, triple-blinded clinical trial involving 35 women has found that active transcranial direct current stimulation (tDCS)—delivered at an intensity of 2mA and across a total of 10 sessions—may be an effective treatment option for patients with fibromyalgia.
This finding...
Rhaeos has announced the successful closing of US$10.5 million in Series A funding, led by the Steele Foundation for Hope, bringing the company’s total funding to more than US$18 million. Other round participants include follow-on investors, Creative Ventures and Lateral Capital.
This funding...
On day two of the Pan Arab Interventional Radiology Society annual meeting (PAIRS; 11–14 February, Dubai, UAE), Riad Salem (Northwestern University, Chicago, USA) took to the podium to give insight into a new frontier in interventional oncology (IO)—yttrium 90...
Athersys, the company developing MultiStem (invimestrocel) cell therapy for critical care indications, announced recently that it has been granted a clinical Type B meeting with the US Food and Drug Administration (FDA).
The company was previously granted Regenerative Medicine Advanced Therapy...
Hospital institutions in Mexico will have access to a single, comprehensive set of stroke certification services through a new collaboration between the Mexican stroke association, Asociación Mexicana de Enfermedad Vascular Cerebral AC (AMEVASC), and the American Stroke Association (ASA).
The ASA, a division of...
Perfuze has secured its first product clearance from the US Food and Drug Administration (FDA) for the company’s Millipede 088 access catheter. The first US clinical procedures with Millipede 088 were successfully performed by physicians at Stony Brook University...
MindMaze has announced the US and EU launch of Izar, which it describes as a “first-of-its-kind”, US Food and Drug Administration (FDA)-listed and CE-marked smart peripheral for patients with impairment in hand motor function.
Izar is designed to fill a...
Ischaemic stroke patients treated with a clot-busting medication and/or mechanical thrombectomy who also received butylphthalide—a novel medication initially compounded from celery seed—experienced milder neurological symptoms with better functioning at three months post-stroke, as compared to stroke patients who had...
IRRAS has announced the publication of the first comparative study detailing the use of the company's novel IRRAflow system. This study, which was conducted under the guidance of Adnan Siddiqui (University of Buffalo, New York, USA) and colleagues, is published in the...
New data on intravenous tenecteplase indicate that it can achieve comparable efficacy and safety to alteplase in treating stroke—and, as such, may be used as an alternative to alteplase for acute ischaemic stroke patients within 4.5 hours of symptom...
A new smartphone application called FAST.AI (Neuronics Medical) may help people who are having a stroke—or their family and caregivers—to recognise common stroke symptoms in real time, prompting them to seek medical care and receive urgent treatment.
FAST.AI is a fully automated...
Phenox, a Wallaby Medical company, has today announced the presentation of the primary results of the PROST (Preset for occlusive stroke treatment) randomised clinical trial at the International Stroke Conference (ISC; 8–10 February 2023, Dallas, USA).
The PROST trial was...
EndoStream Medical has announced that the first patient has been enrolled in the TORNADO-US clinical study in the USA, which will evaluate the Nautilus intrasaccular system in the treatment of cerebral aneurysms.
The patient was treated at Mount Sinai Hospital in New...
An international clinical study has found that patients experiencing a ‘large’ stroke—characterised by a greater infarct-core volume on imaging—had a dramatically better recovery after receiving an endovascular mechanical thrombectomy plus standard medical management than those who received standard medical...
New data pointing to the possible advantages held by several drug products in treating acute ischaemic stroke were delivered at the recent International Stroke Conference (ISC; 8–10 February, Dallas, USA), including novel alternatives to conventional intravenous thrombolytics. Multiple companies...
The administration of medications to lower systolic blood pressure in acute ischaemic stroke patients who have undergone a successful mechanical thrombectomy procedure—also known as endovascular therapy (EVT)—"should be customised", owing to possible safety concerns and only marginal benefits associated...
Hyperfine has announced the presentation of new stroke patient follow-up data regarding the use of the Swoop system—which it claims is the world’s first US Food and Drug Administration (FDA)-cleared portable magnetic resonance imaging (MRI) system—at the 2023 International Stroke...
A study of two widely used cardiovascular medications—cilostazol and isosorbide mononitrate—in more than 350 patients has confirmed that both were well-tolerated and safe for patients experiencing a stroke caused by a clot in a small blood vessel deep in...
Phenox, a Wallaby Medical company, has announced the US Food and Drug Administration (FDA) 510(k) clearance of its Preset thrombectomy device for the treatment of acute ischaemic stroke.
The Preset product family, which has been available in Europe for more...
In a study presented yesterday at the International Stroke Conference (ISC; 8–10 February, Dallas, USA), irregular heart rhythms were detected in roughly one in five people who survived an ischaemic stroke due to atherosclerosis and were continuously monitored for...
Viz.ai and TeleSpecialists have announced new data presented at the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) from the VALIDATE study, which demonstrated that hospital utilisation of Viz’s artificial intelligence (AI)-powered care coordination platform was associated with...
ApTOLL, a neuroprotectant medication intended to shield the brain from tissue damage, has been linked to reduced death and disability when used alongside standard treatments to restore blood flow in ischaemic stroke patients. That is according to preliminary late-breaking...
Avicenna.AI announced today that it has secured a Series A funding round, bringing aggregated investment in the company close to US$10 million. The round was backed by existing investors Innovacom and CEMAG Invest, according to an Avicenna.AI press release.
The...
Imperative Care has announced the formation of digital health startup Kandu Health as an independent company, with the aim of “changing the course of stroke recovery and post-acute care”.
Kandu is set to offer remote clinical support from Kandu Navigators, who...
Intravenous thrombolysis (IVT) prior to a mechanical thrombectomy procedure could result in better functional outcomes than thrombectomy alone in stroke patients with M2 occlusions, as per a retrospective analysis derived from the Endovascular Treatment in Ischemic Stroke (ETIS) registry.
Outlining...
A new American Heart Association (AHA) scientific statement provides guidance on staffing, leadership and resource requirements for hospital stroke centres, with the intention of reducing variability and improving quality of care at stroke centres across the USA.
The statement...
A national study conducted by researchers in the Czech Republic has found that, while stroke admissions in the country declined during the first year of the COVID-19 pandemic, this was not related to the incidence of the virus.
The study’s...
The external validity—in other words, the transferability to real-world clinical practice—of contemporary randomised controlled trials (RCTs) investigating carotid artery stenosis interventions “varies considerably”, as per a recent analysis published in the European Journal of Vascular and Endovascular Surgery (EJVES)...
JMIR Publications has announced the expansion of its journal portfolio with JMIR Neurotechnology (JNT)—an open-access, peer-reviewed journal focused on the intersection between clinical neuroscience and technology to prevent, diagnose, and treat neurological disorders.
Neurosurgeon Pieter Kubben (Maastricht University Medical Center, Maastricht,...
Spinal cord stimulation (SCS) therapies targeting the dorsal column “may be considered” within the multimodal treatment plans typically required by cancer patients, but it is “unclear” which types of cancer-related pain are likely to respond to these therapies. That...
LivaNova has launched SenTiva DUO—an implantable pulse generator (IPG) with a dual-pin header intended to provide vagus nerve stimulation (VNS) therapy for patients with drug-resistant epilepsy.
The dual-pin header distinguishes this latest IPG from the original SenTiva device, which is...
A meta-analysis of recent basilar artery occlusion trials—including ATTENTION and BAOCHE—has further indicated the potential benefits held by endovascular therapy (EVT) in treating posterior-circulation large vessel occlusion (PC-LVO) stroke.
Writing in the Journal of NeuroInterventional Surgery (JNIS), authors Jeremy Heit...
The latest and greatest in neurointerventional technologies feature among NeuroNews’ most read stories from January, including a direct intravascular imaging tool; a new, stroke-specific transradial access system; and two recent introductions to global neurovascular catheter markets. The potential held...
At Stryker, we invest in clinical trials and registries to advance stroke care. In this video, Markus Möhlenbruch discusses the most significant studies that have demonstrated the safety and efficacy of Trevo Retrievers over the last decade. You can count on...
Basking Biosciences has announced that it will be presenting three oral presentations and two moderated posters concerning the company’s novel drug candidate—a reversible thrombolytic agent for ischaemic stroke—at the 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA).
“Current drug...
Axonics has announced that the US Food and Drug Administration has approved the company’s fourth-generation rechargeable sacral neuromodulation (SNM) system—a technology intended to provide patients suffering from overactive bladder and/or faecal incontinence with long-lived, easy to use, safe and...
A systematic review and meta-analysis have demonstrated “convincing evidence” that sex differences exist in carotid atherosclerosis, with all types of plaque features—including those relating to size, composition, and morphology—found to be either larger or more common in men than...
Esteemed neurologist Ralph Sacco passed away at the age of 65 earlier this month, and a number of prominent neurology and stroke societies have since paid tribute to him and his achievements in the field.
Sacco’s obituary in the journal...
Combination spinal cord stimulation (SCS) therapy with Boston Scientific’s WaveWriter system has demonstrated superior outcomes to conventional medical management (CMM) in chronic pain patients with no prior back surgery, as per randomised controlled trial (RCT) data presented recently at...
A systematic review of interventional acute ischaemic stroke treatments in Latin American countries has found that mechanical thrombectomy usage in these regions is “comparable to international levels”. Writing in the Journal of Stroke and Cerebrovascular Diseases, Alejandro Gonzalez-Aquines (University...
Infinity Neuro announced today that its Inspira aspiration catheters have received CE-mark approval and are now commercially available in Europe.
This is the first offering from Infinity—a company that plans to launch a full range of products for the treatment of...
Abbott has announced that the US Food and Drug Administration (FDA) has approved its Proclaim XR spinal cord stimulation (SCS) system to treat painful diabetic peripheral neuropathy (DPN)—a debilitating complication of diabetes.
The Proclaim XR SCS system can provide relief...
A double-blinded randomised controlled trial (RCT) has shown that transcutaneous auricular vagus nerve stimulation (taVNS) can improve cognitive performance in patients with mild cognitive impairment (MCI), offering evidence that this “inexpensive, effective and innovative” technique could be recommended to...
The CELLO II balloon guide catheter (Fuji Systems Corporation) has received 510(k) premarket approval from the US Food and Drug Administration (FDA), and can now be marketed in the USA and other FDA-regulated territories for peripheral and neurovascular indications.
Having...
Blackford—an artificial intelligence (AI) imaging platform and solutions provider—is set to form a strategic partnership with Brainomix to bring the latter’s comprehensive e-Stroke solution to the Blackford Platform, making advanced stroke care available to more institutions around the world.
"Timely...
Researchers have explored the therapeutic outcomes of patients with brain arteriovenous malformations (AVMs) in mainland China and produced early findings indicating that microsurgery is the “dominant” strategy for this indication, and treatment protocols based around disease severity are the...
A study conducted by Michigan Medicine (Ann Arbor, USA) researchers suggests that hospitals without the highest stroke care designation may be missing strokes that occur after transcatheter aortic valve implantation (TAVI)—a common, minimally invasive procedure whereby a patient’s thickened...
Recently published data from the ENCHANTED2/MT study have shed new light on the safety and efficacy of more intensive versus less intensive blood pressure lowering after mechanical thrombectomy procedures in large vessel occlusion (LVO) stroke patients.
The key finding from...
A multi-year clinical trial at the University of Texas Medical Branch (UTMB; Galveston, USA) and Medical University of South Carolina (MUSC; Charleston, USA) will examine the use of a wearable device designed to stimulate nerves near the ear and...
MedRhythms has announced that the company's pivotal trial for MR-001, a novel digital intervention being developed to treat gait deficits in chronic stroke, was successfully completed and met its primary endpoint of improvement in gait speed.
The multi-site randomised controlled...
Basecamp Vascular (BCV) has announced the appointment of Thierry Col as its new CEO, effective 1 February 2023.
He succeeds interventional neuroradiologist Raphaël Blanc (Foundation Rothschild Hospital, Paris, France), the company’s co-founder and president, who has held this role since the...
This advertorial is sponsored by Philips.
Time is of the essence when treating a patient who has just experienced a stroke. Every minute counts, and minimising the number of minutes a stroke is left untreated could be the difference for...
Stroke symptoms that disappear in under an hour—often referred to as a transient ischaemic attack (TIA)—need emergency assessment to help prevent a full stroke, according to a new American Heart Association (AHA) scientific statement published today in the association’s...
The Squid liquid embolic agent (Balt) has been deemed safe and effective in treating high-grade dural arteriovenous fistulas (DAVFs), and serves to expand the armamentarium for neurointerventionists treating DAVFs and other intracranial vascular malformations.
Markus Möhlenbruch (Heidelberg University Hospital, Heidelberg,...
Saluda Medical has announced that late-breaking data from the "landmark" EVOKE clinical trial was presented at the recent North American Neuromodulation Society (NANS) annual meeting (12–15 January 2023, Las Vegas, USA). The data presented constitute “the longest follow-up evidence...
A newly published meta-analysis of individual patient data has found that older patients with symptomatic carotid disease are likely to benefit as much from timely intervention as younger patients. Speaking to Vascular News in light of this key finding,...
An international study conducted by Leonard Yeo (National University Hospital, Singapore) and colleagues has found that the presence of atrial fibrillation does not modify the treatment effect of bridging intravenous thrombolysis (IVT) in ischaemic stroke patients undergoing a thrombectomy...
Abbott presented new data in more than 30 presentations and posters at the North American Neuromodulation Society (NANS) annual meeting (12–15 January 2023, Las Vegas, USA), highlighting how neuromodulation can help people suffering from chronic pain and movement disorders,...
A study by the Neiman Health Policy Institute (Reston, USA) has found that the costs of an ischaemic stroke episode increased by 4.9% from 2012 to 2019, with the main driver of this being changes in treatments—such as endovascular...
Neuralace Medical has announced the commencement of and first patient enrolments in its AT-PDN (Axon therapy and painful diabetic neuropathy) study.
The multicentre AT-PDN study has a targeted enrolment of 80 patients and will be led by Lora Brown (TruWell Health, St...
The “renaissance” of neuro- and cerebroprotective paradigms, coupled with “the advent of new ideas”—such as the concept of ‘transient neuroprotection’ to preserve the penumbra—appears to offer promise in interventional stroke care. This was arguably the prevailing message offered by...
Gentuity has today announced the first human use of the Vis-M high-frequency optical coherence tomography (HF-OCT) imaging system and probe. As per a company press release, this represents a “significant technological advance for the field of neurointervention”, making high-resolution...
A systematic review and meta-analysis of the “scarce” existing literature has adjudged flow diversion with a coated stent plus single antiplatelet therapy (SAPT) to be “feasible” in the treatment of ruptured intracranial aneurysms, despite thromboembolic complications occurring in a...
Athersys, the company developing MultiStem (invimestrocel)—an off-the-shelf stem cell treatment intended for critical care indications, including acute ischaemic stroke, trauma and other inflammatory conditions—has provided an update regarding two ongoing clinical trials with this product.
The MASTERS-2 trial is attempting to...
Medtronic has announced that it will highlight clinical and preclinical research relating to sensing-enabled spinal cord stimulation (SCS) therapy at the North American Neuromodulation Society (NANS) annual meeting (12–15 January 2023, Las Vegas, USA).
In addition, Medtronic and its partners...
A career in clinical research is perhaps a less formulaic and well-trodden path than the one into medicine itself, typically requiring relatively young and inexperienced clinicians to show initiative, commitment and a great deal of patience. According to Diederik...
Synchron has announced that the medical journal JAMA Neurology has published peer-reviewed, long-term safety results from a clinical study in four patients with severe paralysis implanted with the company’s first-generation Stentrode neuroprosthesis device. The study found that it is...
Fluidx Medical has released information regarding the success of the IMPASS Embolic Device in in vivo research related to middle meningeal artery (MMA) embolisations that can be used to treat chronic subdural haematomas (CSDH) on the surface of the...
A recent update on the DISTAL randomised controlled trial (RCT)—which was delivered at the Barts Research and Advanced Interventional Neuroradiology (BRAIN) conference (5–8 December 2022, London, UK)—saw attendees discuss the study’s strengths, and how far it could go towards...
Justin Zenanko, the CEO of SynerFuse, announced today that—in what the company says is a world-first—a solo spine surgeon has performed the “groundbreaking” SynerFuse procedure.
Rohan Lall (M Health Fairview, Minneapolis, USA) simultaneously performed both a spinal fixation procedure and...
Nalu Medical—a company working on miniaturised neurostimulation implants for the management of chronic intractable pain via both spinal cord stimulation (SCS) and peripheral nerve stimulation (PNS) indications—has announced the publication of two key studies in Neuromodulation: Technology at the Neural...
The final weeks of 2022 saw the global burden of stroke gain a great deal of attention from NeuroNews’ online audience, including discussions around improving access to thrombectomy treatments in the UK. Established techniques and novel technologies alike feature...
Researchers from India have developed a patient-specific mathematical model to examine and elucidate the parameters—including shape and size—that influence aneurysm rupture risks prior to surgical intervention.
Predicting the rupture of cerebral aneurysms is crucial for medical prevention and treatment, as...
Nevro Corporation has announced that two abstracts for clinical trials relating to painful diabetic neuropathy (PDN) and non-surgical back pain (NSBP) treatments have been accepted as podium presentations at the upcoming North American Neuromodulation Society (NANS) annual meeting (12–15...
A new study funded by the Heart and Stroke Foundation has revealed that annual stroke occurrence rates in Canada have increased to 108,707—roughly one every five minutes. This highlights the need for strong stroke care, treatment and recovery systems across the country, as...
Imperative Care announced today that the US Food and Drug Administration (FDA) has finalised 510(k) clearance of its Zoom RDL radial access system—the company’s latest innovation in elevating stroke care and the “first radial access platform developed specifically for...
Abbott has announced the US Food and Drug Administration (FDA) approval of the company's Eterna spinal cord stimulation (SCS) system, which it claims is the smallest implantable, rechargeable spinal cord stimulator currently available on the market for the treatment...
Insightec recently announced it has received an additional US Food and Drug Administration (FDA) approval for treatment of essential tremor using its Exablate Neuro platform.
Essential tremor commonly affects both sides of the body, and this new FDA approval will...
A patient’s race may influence the recommendations they receive for the surgical removal of brain tumours, as per a recent, registry-based cohort analysis published in The Lancet by University of Minnesota Medical School (Minneapolis, USA) researchers.
According to the analysis,...
A team including researchers from the USA, Germany and Canada has found that stimulating a specific network in the brain of Alzheimer’s disease patients can reduce their symptoms, recently publishing these findings in Nature Communications. The researchers hope their...
The thrombolysis taskforce of the European Stroke Organisation (ESO) executive committee has provided an update on current shortages of alteplase and tenecteplase, detailing outcomes from a recent meeting with Boehringer Ingelheim (BI)—the company that markets both drugs in Europe—and...
Saluda Medical has announced plans for a limited commercial release of its Evoke spinal cord stimulation (SCS) system in the USA, with a full commercial release expected in 2023.
The Evoke system is the first and only US Food and Drug...
Through her many years as a consultant neuroradiologist at the North Bristol NHS Trust (Bristol, UK), as well as organising the European Course in Minimally Invasive Neurological Therapy (ECMINT) and making leading contributions to the UK Neurointerventional Group, Shelley...
A transmural approach for accessing the perivascular tissues of the cervical carotid artery has been deemed safe following initial evaluations in a swine model.
Geoffrey Colby, Wi Jin Kim and Milan Samarage (all University of California Los Angeles , Los...
The utilisation of 3D printing to make drug-eluting stents may currently be in its infancy, but the advantages it carries—such as the ability to develop patient-specific devices and tailored drug-release profiles, and evaluate different materials and designs via computational...
Closed-loop evoked-interference deep brain stimulation (DBS) has been shown to be potentially utilisable in characterising the role of oscillatory dynamics in Parkinson’s disease and other brain conditions—indicating that this DBS modality could play a role in developing personalised neuromodulation...
Sonorous NV has announced the treatment of the first patients in North America with the BossStent device, which is designed to treat patients with symptomatic cerebral venous diseases.
As per a Sonorous press release, the single-use, implantable device acts as...
Stryker recently opened its Neurovascular (NV) lab—a “state-of-the-art” laboratory designed to accelerate stroke-related innovation in the Asia-Pacific region. Located within the Stryker Global Technology Center (SGTC) at International Park in Gurgaon, India, the Keystone Suite will enable collaboration between...
This educational supplement has been sponsored by MicroVention.
Since its inception in 1997, MicroVention has gradually expanded its offerings from cerebral aneurysms to include several other areas in neuroendovascular care—with ischaemic stroke being a key area of focus over the...
Permanent intracranial stenting offers a feasible, safe ‘bailout’ option following a failed mechanical thrombectomy procedure. This was the concluding message delivered recently by Sarah Power (Beaumont Hospital, Dublin, Ireland)—who highlighted stenting’s association with improved successful recanalisation rates (thrombolysis in...
Highlights:
With the UK Stroke Association continuing its push to make thrombectomy treatments more widely accessible, NeuroNews speaks to Sanjeev Nayak (Stoke-on-Trent, UK), Dileep Yavagal (Coral Gables, USA) and Michihiro Tanaka (Kamogawa, Japan) to gain global perspectives
"So, you...
Highlights:
With the UK Stroke Association continuing its push to make thrombectomy treatments more widely accessible, NeuroNews speaks to Sanjeev Nayak (Stoke-on-Trent, UK), Dileep Yavagal (Coral Gables, USA) and Michihiro Tanaka (Kamogawa, Japan) to gain global perspectives
"So, you...
Medtronic Neurovascular has announced a new partnership with Avail Medsystems, creating the Medtronic Remote Connectivity Program (Medtronic RCP) in the process.
The goal of this collaboration is to enable real-time connectivity with peers, thought leaders, and other industry experts, according...
Corindus has been rebranded to Siemens Healthineers Endovascular Robotics and will sit as a dedicated business within the Advanced Therapies area of Siemens Healthineers, the company has announced.
This brand unification is the final step of the company integration process...
Despite their clear significance in pain management, gender differences relating to the ways patients respond to neuromodulation therapies are relatively poorly understood and underpinned by a limited amount of definitive data. Beatrice Bretherton (Leeds, UK) discusses this existing evidence...
Axonics has announced that Health Canada has approved the company’s fourth-generation rechargeable sacral neuromodulation system as a treatment for bladder and bowel dysfunction.
The newly approved Axonics R20 neurostimulator is labelled for a functional life in the body of at least...
IRRAS has announced that it recently received regulatory clearance from the US Food and Drug Administration (FDA) to activate all of the functionality on the next-generation control unit for its flagship product, IRRAflow—which it claims is the world's first...
Eight winners have been exclusively invited to join Phase 2 of the Neuromod Prize, a US$9.8 million competition to accelerate the development of targeted neuromodulation therapies. With the competition, the National Institutes of Health (NIH) hopes to “bridge the...
Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the transition period for the implementation of the European Union’s (EU) Medical Device Regulation (MDR) will be put forward in early 2023.
Kyriakides informed health ministers from the EU’s...
NeuroOne Medical Technologies has announced that it has successfully completed a feasibility study with its OneRF ablation system—a developing technology that utilises existing implanted stereoelectroencephalography (sEEG) diagnostic electrodes for brain tissue lesioning.
The study evaluated the company's new radiofrequency (RF)...
Key announcements from a number of the neurovascular market's leading companies generated interest from NeuroNews' online readers last month, including updates from the recent Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–19 November 2022, Los Angeles, USA)....
Renowned pain management expert and clinical professor of anaesthesiology Timothy Deer (West Virginia University, Charleston, USA) is set to receive the inaugural Presidential Merit Award from the North American Neuromodulation Society (NANS).
This award—which is a new introduction for 2023—has...
A study published in Neurology has found that the burden of ischaemic stroke in young adults “continues to increase” across low-socio-demographic index (SDI) regions, such as North Africa and the Middle East, and Southeast Asia. As such, the study’s...
“We are entering an era where true scientific evidence from IONM is guiding technology and our clinical practice.” This was one of the salient messages delivered by Steven Falowski (Argires Marotti Neurosurgical Associates of Lancaster, Lancaster, USA) at...
Health charities and National Health Service (NHS) clinicians have united in a call for the Scottish government to reverse a cut to the funding of stroke thrombectomy treatments.
More than 150 stroke clinicians have backed a call from charities Chest,...
A wealth of new data confirming the beneficial role mechanical thrombectomy can play in the treatment of acute ischaemic stroke came to light through the 2010s, but global healthcare systems are still fighting to make these procedures available for...
NOTE: This video is ONLY available to watch in selected countries and geographies
Principal investigators Urs Fischer (University Hospital of Basel, Basel, Switzerland) and Jan Gralla (University Hospital of Bern, Bern, Switzerland) provide insights on the results from SWIFT-DIRECT—a...
A prospective study has demonstrated the potential feasibility, applicability and accuracy held by artificial intelligence (AI) in the detection of carotid artery disease on greyscale static duplex ultrasound imaging. This is the conclusion reached by Ali Kordzadeh (Faculty of...
Wise, a company that develops next-generation implantable electrodes for neuromonitoring, neuromodulation and brain-machine interfacing applications, has announced the US Food and Drug Administration (FDA) clearance of its Wise Cortical Strip (WCS)—a single-use medical device intended to be used on the...
LuSeed Vascular has announced that Robert Stern, an experienced medical device executive and investor, has been nominated as the vice chairman of the company’s board of directors.
Stern currently serves as an advisor to several medical device companies and...
The Society of NeuroInterventional Surgery (SNIS) has released a position statement advocating pregnancy and parental leave policies in neurointerventional surgery, also voicing support for a physician’s ambition to have a family, as well as start, develop and maintain a...
NeuroPace has announced that the first patient with Lennox-Gastaut syndrome (LGS)—a particularly severe form of childhood-onset epilepsy characterised by cognitive dysfunction and frequent seizures—was recently treated in its feasibility investigational device exemption (IDE) study.
The study will see the company’s...
Viz.ai has announced a partnership with Cercare Medical that will incorporate the latter’s Cercare Perfusion—a fully-automated, simple-to-use, patient-specific perfusion software—into the Viz artificial intelligence (AI) platform.
In a press release, Viz.ai states that it is broadening its imaging features and...
Neurologica, a subsidiary of Samsung Electronics, has announced that its head-to-toe trauma imaging solution—the BodyTom 64 point-of-care mobile computed tomography (CT) scanner—has received 510(k) clearance from the US Food and Drug Administration (FDA) for commercial use in the USA.
Based on...
Two neurosurgeons from Tufts Medical Center in Boston, USA have been honoured with the 2022 Innovation Award at this year’s Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–19 November, Los Angeles, USA) for their work on an...
The Swiss Federal Assembly has voted in favour of accepting medical devices with US Food and Drug Administration (FDA) marketing authorisation in Switzerland.
A motion for ‘more freedom of action in the procurement of medical products for supply of the...
The ongoing annual meeting of the Radiological Society of North America (RSNA; 27 November–1 December 2022, Chicago, USA) has seen a plethora of new research findings presented relating to various brain conditions—including attention-deficit/hyperactivity disorder (ADHD) in children, migraine-related brain...
Following the presentation of first-in-human cases with the GECKO system at the 2022 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (7–9 September, Nice, France), Basecamp Vascular (BCV) CEO and co-founder Raphaël Blanc (Foundation Rothschild Hospital, Paris, France)...
Vesalio has today announced the appointment of a new vice president (VP) of US sales, Bob Bushok, who will oversee commercial strategy and execution for the Neva VS vasospasm launch and the expected 2023 introduction of the Neva thrombectomy...
Abbott has been recognised by the Consumer Technology Association (CTA) with three Consumer Electronics Show (CES 2023; 5–8 January, Las Vegas, USA) Innovation Awards for multiple technologies that are said to be “advancing the health tech industry and improving...
